{
  "meta": {
    "title": "Obstetrics_And_Gynaecology_Test_-_1",
    "url": "https://brainandscalpel.vercel.app/obstetrics-and-gynaecology-test-1-f52f6601.html",
    "scrapedAt": "2025-11-30T12:48:41.948Z"
  },
  "questions": [
    {
      "text": "The image below shows the hysterosalpingogram of a 37-year-old nulliparous woman. Identify the false statement about this finding.",
      "choices": [
        {
          "id": 1,
          "text": "It is a thick walled structure on sonography"
        },
        {
          "id": 2,
          "text": "It can be asymptomatic"
        },
        {
          "id": 3,
          "text": "Tubal plicae are flattened on histology"
        },
        {
          "id": 4,
          "text": "Sequelae of pelvic inflammatory disease"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image shows <strong>bilateral hydrosalpinx</strong>. It appears as a<strong> thin-walled</strong>&nbsp;structure.&nbsp;</p>\n<p>A hydrosalpinx is a&nbsp;chronic cystic swelling of the fallopian tube that forms after a distal tubal obstruction.&nbsp;The tubes are enormously distended due to filling with clear serous fluid and become&nbsp;<strong>retort-shaped. </strong>On histology, the<strong> tubal plicae</strong> appear <strong>flattened.</strong>&nbsp;The interstitial end of the tube is open whereas the fimbrial end is indrawn and closed. This permits the <strong>dye</strong> to <strong>enter</strong> but <strong>not exit</strong> the tube during HSG.&nbsp;</p>\n<p>It is caused due to:&nbsp;</p>\n<ul>\n<li>Pelvic inflammatory disease&nbsp;</li>\n<li>Endometriosis&nbsp;</li>\n<li>Tuberculosis - tubercular salpingitis may also cause tobacco-pouch appearance, lead pipe appearance and pyosalpinx</li>\n<li>Fallopian tube neoplasms (rare)</li>\n</ul>\n<p>It can be an incidental finding during a pelvic exam or ultrasound. The patient may be&nbsp;<strong>asymptomatic,</strong>&nbsp;or present with infertility or chronic pelvic pain<strong>.</strong>&nbsp;</p>\n<p>On HSG, it appears as&nbsp;<strong>terminal sacculation </strong>and<strong> occlusion </strong>of both <strong>fallopian tubes </strong>with a normal uterine cavity. Usually, a&nbsp;<strong>thin-walled,</strong> hypoechoic, cystic structure is seen. However, it may appear as&nbsp;multiple hyperechoic mural nodules around the inner circumference of the tube creating a 'beads on a string' appearance.</p>\n<p>Treatment:</p>\n<ul>\n<li>Treat the underlying cause</li>\n<li>Laparoscopic salpingostomy - in mild disease&nbsp;</li>\n<li>IVF recommended for women with infertility and severe hydrosalpinx</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a4c8d71f448b4482bfe9bf4611b77760x510x411.GIF\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/e88108107de64fc9a93675782c8642e4.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0009",
      "difficulty": "hard"
    },
    {
      "text": "A 33-year old P3L3 woman complained of intermenstrual bleeding. On speculum examination, a polypoid lesion was visualized in the cervix, which was confirmed with the ultrasound shown below. What is the most appropriate management?",
      "choices": [
        {
          "id": 1,
          "text": "Wait and watch with serial sonograms"
        },
        {
          "id": 2,
          "text": "Removal with ring forceps"
        },
        {
          "id": 3,
          "text": "Oral contraceptive pills"
        },
        {
          "id": 4,
          "text": "Embolization of feeding vessel"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p class=\"p1\">The above ultrasound image shows the presence of an <strong>endocervical polyp</strong>. The most appropriate treatment is <strong>avulsion using ring forceps</strong>.</p>\n<p class=\"p1\">Endocervical polyps are overgrowths of benign endocervical stroma covered by mucinous columnar epithelium. They appear as single, red, smooth elongated masses arising from the endocervical canal. Polyps range from a few millimeters to 2-3 cm in size and are more frequently seen in multiparas.</p>\n<p class=\"p1\">Endocervical polyps are usually asymptomatic, but also cause intermenstrual or postcoital bleeding or vaginal discharge. They are identified by inspection during a pelvic examination or&nbsp;during transvaginal sonography if they are located higher up.</p>\n<p class=\"p1\">They are typically benign. Premalignant or malignant transformation is rare. However, cervical cancer can also present as polypoid masses and can mimic these benign lesions.</p>\n<p class=\"p1\">Treatment:</p>\n<ul>\n<li class=\"p1\">Asymptomatic polyps usually don't need any intervention</li>\n<li class=\"p1\">Symptomatic:\n<ul>\n<li class=\"p1\"><strong>Removal with ring forceps</strong>: The polyp is twisted repeatedly about the base of its stalk to strangulate its feeding vessels. With a repeated twisting, the base will narrow and avulse.</li>\n<li class=\"p1\"><strong>Removal with punch biopsy forceps</strong> for smaller polyps</li>\n<li class=\"p1\"><strong>Electrosurgical excision or hysteroscopic removal</strong> for polyps with thick stalks</li>\n</ul>\n</li>\n</ul>\n<p>After the removal of polyps, the base can be cauterized to prevent bleeding and recurrence rate. Every excised polyp should be sent for further histological examination to rule out malignancy.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/76917fe6c37e4e1287544f5acc25acba.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0010",
      "difficulty": "hard"
    },
    {
      "text": "Match the following methods of postcoital contraception to their doses.<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td><strong>Method</strong></td>\n<td><strong>Dose</strong></td>\n</tr>\n<tr>\n<td>1. Plan B</td>\n<td>A.&nbsp;Two 60 mg tablets to be taken at an interval of 12 hours&nbsp;</td>\n</tr>\n<tr>\n<td>2. Yuzpe</td>\n<td>B. 100&micro;g ethinyl estradiol and 0.5 mg of Levonorgestrel, 2 tablets given 12 hours apart</td>\n</tr>\n<tr>\n<td>3. Centchroman</td>\n<td>C. One 30 mg tablet&nbsp;</td>\n</tr>\n<tr>\n<td>4. Ulipristal</td>\n<td>D.&nbsp;Two 0.75mg tablets to be taken stat and after 12 hours&nbsp;</td>\n</tr>\n<tr>\n<td>5. Plan B-one step</td>\n<td>&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-D, 2-B, 3-A, 4-C"
        },
        {
          "id": 2,
          "text": "1-A, 2-C, 3-D, 4-B"
        },
        {
          "id": 3,
          "text": "1-B, 2-D, 3-C, 4-A"
        },
        {
          "id": 4,
          "text": "1-A, 2- D, 3-B, 4-C"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct answer is <strong>1-D, 2-B, 3-A, 4-C.</strong></p>\n<p><strong>Methods of Emergency contraception</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Drug</strong></td>\n<td><strong>Dose</strong></td>\n</tr>\n<tr>\n<td>Levonorgestrel (Plan B single step)</td>\n<td>1.5mg tablet stat up to 120 hours after unprotected intercourse</td>\n</tr>\n<tr>\n<td>Levonorgestrel (Plan B- 2 steps)</td>\n<td>0.75mg tablet stat and after 12 hours</td>\n</tr>\n<tr>\n<td>\n<p>Ethinyl estradiol 100 &mu;g + Levonorgestrel 0.5 mg</p>\n<p>(Yuzpe method)</p>\n</td>\n<td>2 tablet stat and 2 tablets after 12 hours</td>\n</tr>\n<tr>\n<td>\n<p>Centchroman (Chhaya or Saheli)</p>\n</td>\n<td>&nbsp;2 tablets(60 mg) to be taken twice in 24 hours, and within 24 hours of intercourse.</td>\n</tr>\n<tr>\n<td>Ulipristal</td>\n<td>&nbsp;30 mg within 5 days</td>\n</tr>\n<tr>\n<td>Conjugated estrogen</td>\n<td>15 mg BD x 5 days</td>\n</tr>\n<tr>\n<td>Ethinyl Estradiol</td>\n<td>2.5 mg BD X 5 days</td>\n</tr>\n<tr>\n<td>Copper IUDs</td>\n<td>Insertion within 5-7 days after accidental unprotected exposure.Not suitable for rape victims</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Hormonal contraceptives</h3><div dir=\"ltr\">\n<p><strong>Oral pills:</strong></p>\n<ul>\n<li>Combined oral contraceptive pills (COC)\n<ul>\n<li>Mala D -&nbsp;Levonorgestrel 0.15 mg + Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate</li>\n<li>Mala N -&nbsp;Levonorgestrel 0.15 mg +&nbsp;Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate&nbsp;(Govt. supply, free of cost)</li>\n</ul>\n</li>\n<li>Progesterone only pills (POP) - suitable for lactating women\n<ul>\n<li>Norethisterone 350 &mu;g</li>\n<li>Norgestrel 75 &mu;g</li>\n<li>Levonorgestrel (LNG) 30 &mu;g</li>\n</ul>\n</li>\n<li>Once a month or long-acting pills - highly disappointing results\n<ul>\n<li>Quinestrol (long-acting estrogen) + short-acting progesterone</li>\n</ul>\n</li>\n<li>Gossypol - male pill : Cottonseed derivative and causes azoospermia and severe oligospermia</li>\n<li>Post-coital pills or interceptive\n<ul>\n<li>Levonorgestrel 0.75 mg, 2 doses, 12 hours apart</li>\n<li>Mifepristone 10-600 mg</li>\n<li>Ulipristal 30 mg, within 5 days of intercourse</li>\n<li>Centchroman 60 mg, 2 tablets, within 24 hrs of intercourse</li>\n<li>GnRH agonists &nbsp;</li>\n<li>CuT IUCD, inserted within 5 days</li>\n</ul>\n</li>\n</ul>\n<p><strong> Injectable contraceptives</strong></p>\n<ul>\n<li>Progesterone only injectables\n<ul>\n<li>DMPA&nbsp;150 mg IM every 3 months</li>\n<li>NET-EN&nbsp;200 mg IM every 2 months</li>\n</ul>\n</li>\n<li>Combined injectables\n<ul>\n<li>Cyclofem - DMPA 25 mg + Estradiol cypionate 5 mg</li>\n<li>Mesigyna - NET-EN 50 mg &nbsp;+ Estradiol valerate 5 mg</li>\n</ul>\n</li>\n</ul>\n<p><strong> Subdermal implants</strong></p>\n<ul>\n<li>Norplant I -&nbsp;Levonorgestrel 35 mg</li>\n<li>Norplant II or Jadelle -&nbsp;2 rods with levonorgestrel 70 mg in each and released at a rate of 50 &mu;g/day &nbsp;</li>\n</ul>\n<p><strong>Others</strong></p>\n<ul>\n<li>Hormonal IUCD -&nbsp;Mirena which contains LNG 52 mg with release rate of&nbsp;20 &mu;g/day</li>\n<li>Orthoevra patch -&nbsp;Norelgestomin + Ethinyl estradiol weekly for 3 weeks, then patch free for 1 week</li>\n<li>Vaginal ring or Nuvaring - Etonogestrel + ethinyl estradiol daily release, use for 3 weeks with withdrawal for 1 week</li>\n</ul>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0012",
      "difficulty": "medium"
    },
    {
      "text": "A 45-year-old lady visits the Gynecology clinic for a routine check-up, during which her physician schedules a screening test for cervical cancer. Identify the correct statement about the test.<div class='question-desc-html'><ol>\n<li>Need not be deferred due to unexplained bleeding.</li>\n<li>1 week of abstinence from intercourse is required.</li>\n<li>Ayre's spatula samples the endocervix.</li>\n<li>Cytobrush samples the ectocervix.</li>\n<li>The broom is rotated 5 times in the same direction.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "1 and 5"
        },
        {
          "id": 2,
          "text": "1, 3 and 5"
        },
        {
          "id": 3,
          "text": "2, 4, and 5"
        },
        {
          "id": 4,
          "text": "3 and 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Statements <strong>1 and 5 are correct&nbsp;</strong>regarding the&nbsp;screening test for cervical cancer -the <strong>Pap/&nbsp;Papanicolaou test.</strong></p>\n<p>Before the Pap test:</p>\n<ul>\n<li>The Pap test should&nbsp;not be deferred due to unexplained discharge or unscheduled bleeding as they may be signs of cervical or other genital tract cancers.</li>\n<li>Ideally scheduled to avoid menstruation. It is best performed around the time of ovulation.</li>\n<li>Patients should abstain from vaginal intercourse, douching, tampon use, and intravaginal medications for a minimum of <strong>24 to 48 hours prior</strong> to the test.</li>\n<li>Avoid touching the cervix before performing the Pap test, as dysplastic epithelium may get removed.</li>\n<li>Ideally, confirmed cervicitis or vaginitis should be treated prior to the test</li>\n</ul>\n<p>Procedure:</p>\n<ul>\n<li>The patient is put in a dorsal position and Cusco&rsquo;s self-retaining speculum is introduced.</li>\n<li>The squamocolumnar junction is scraped with <strong>Ayre&rsquo;s spatula&nbsp;</strong>completing at least one full rotation. It&nbsp;predominantly samples the <strong>ectocervix</strong>.&nbsp;</li>\n<li><strong>Endocervix</strong> is scraped with a <strong>cytobrush,&nbsp;</strong>which is rotated only one-quarter to one-half turn after the ectocervix has been sampled.</li>\n<li>A <strong>broom</strong> simultaneously samples both endo- and ectocervix.&nbsp;<strong>Five rotations</strong> in the<strong> same direction</strong> are recommended, since reversing direction may cause loss of cellular material.&nbsp;</li>\n<li>Samples are spread separately on 2 different glass slides and fixed using 95% ethyl alcohol.</li>\n<li>Stained with Pap stain or Short stain.</li>\n</ul>\n<p>The image below shows the instruments used in cervical sampling: The broom, spatula, and cytobrush in order.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8bc86785838a498b8b655e9a3b18a261x353x660.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0015",
      "difficulty": "medium"
    },
    {
      "text": "A sterilisation procedure is being performed on a 32-year old P2L2 woman. During the procedure, the mid-portion of the fallopian tube is ligated and the intervening portion is excised. The proximal tubal stump is mobilized, buried and embedded into a pocket of myometrium. The distal tubal stump is buried between leaves of the broad ligament. Which of the following is the correct statement about this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "It is called Uchida technique"
        },
        {
          "id": 2,
          "text": "Completely reversible"
        },
        {
          "id": 3,
          "text": "Reliable method of sterilization"
        },
        {
          "id": 4,
          "text": "Cannot be done in conjunction with C section"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The procedure described is the&nbsp;<strong>Irving</strong> <strong>procedure </strong>which is a<strong> reliable method</strong> of sterilization. It involves ligating and excising the mid-portion of the tube after which<strong>&nbsp;the proximal stump is buried into the myometrium</strong>. The distal stump is buried in the broad ligament.</p>\n<p>It is often done in conjunction with caesarian sections.</p>\n<p>It is <strong>not a reversible</strong> technique and may require a laparotomy incision.&nbsp;Failure rates are less than 1 case in 1000 patients, making it a reliable method.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/726c7c4a4ba8431797c18a30b35c0d91x1280x996.JPEG\" alt=\"Explanation Image\"><p><strong>Uchida</strong> <strong>technique</strong> involves <strong>stripping the tubal serosa</strong> from the muscular layer in the midsegment of the tube, followed by ligation and excision of the stripped portion. The <strong>proximal stump </strong>is<strong> buried </strong>in the <strong>broad ligament</strong> while the distal stump is left open to the peritoneal cavity. This minimal tubal excision preserves the potential for tuboplasty.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/be8c79a15f2a4446a631f2e09880c129x1280x2110.JPEG\" alt=\"Explanation Image\"><p>Other methods of sterilization include:</p>\n<ul>\n<li>Laparotomy/Minilaparotomy:\n<ul>\n<li><strong>Pomeroy's procedure</strong>: The fallopian tube is identified on each side, brought out through the incision, and the middle portion is formed into a&nbsp;<strong>loop</strong>&nbsp;which is tied at the base with catgut and&nbsp;<strong>excised</strong>. It is surgically&nbsp;<strong>reversible.</strong></li>\n<li><strong>Madlener's procedure:</strong>&nbsp;A loop of the fallopian tube is&nbsp;<strong>crushed</strong>&nbsp;and then ligated with a nonabsorbable suture.</li>\n<li><strong>Kroener's technique:&nbsp;</strong>It refers to&nbsp;<strong>fimbriectomy</strong>&nbsp;done by ligating the distal ampulla of the tube with two permanent sutures followed by division and removal of the infundibulum. It is irreversible.</li>\n<li><strong>Aldridge method</strong>: A hole is made in the anterior leaf of the broad ligament and the fimbrial end is buried into this.</li>\n<li><strong>Cornual resection</strong>: The cornual part of the tube is resected between two clamps.</li>\n</ul>\n</li>\n<li><strong>Laparoscopic techniques:&nbsp;</strong>\n<ul>\n<li>Each fallopian tube is picked up near the isthmic end (2&ndash;3 cm away) and clipped or banded with silastic bands, Filshie clips, Hulka band, or falope silastic rings. It is a reversible technique.</li>\n</ul>\n</li>\n<li><strong>Hysteroscopic sterilization</strong>&nbsp;with the&nbsp;<strong>Essure permanent device: </strong>It<strong>&nbsp;</strong>causes a benign local fibrous tissue growth that occludes the fallopian tube. It takes 3 months to occlude the tube, confirmed with hysterosalpingography. During this period of 3 months, other methods of contraception should be used. It is an irreversible technique.&nbsp;</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/43db578459644fd7b5803c2cca560c24x1280x973.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/00c9a06bc89e44d38eae4c6e218d43cfx1280x973.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4e845e069b1f48c18bac26dd8d431628x1280x992.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/146a6db33c1a47fa9c6fe43d2a00d02ex1280x2560.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/783e5480553d4146a6be0470d8f666eax1200x1451.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0039",
      "difficulty": "medium"
    },
    {
      "text": "A gynecologist is examining a 28-year-old female patient. On performing a per vaginal examination, the lowest part of the cervix that can be palpated is the anterior lip. What information does that convey about the position of the uterus and cervix?",
      "choices": [
        {
          "id": 1,
          "text": "External os is directed forwards and downwards"
        },
        {
          "id": 2,
          "text": "Uterus is flexed backwards on cervix"
        },
        {
          "id": 3,
          "text": "External os is directed backwards and downwards"
        },
        {
          "id": 4,
          "text": "Uterus is directed backwards and downwards"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>If the examining fingers palpate the anterior lip as the lowest part of the cervix, it means that the uterus is <strong>anteverted</strong> and <strong>the external os is directed downwards and backwards.</strong></p>\n<p>The <strong>normal</strong> position of the uterus is <strong>antiflexed and anteverted</strong>, ie the body of the uterus is flexed forwards on the cervix and the external os is directed downwards and backwards.</p>\n<p>In a <strong>retroverted uterus</strong>, the external os of the cervix is directed <strong>downwards </strong>and<strong> forwards.</strong> The lowest part of the cervix palpated is the <strong>posterior lip. </strong>The body of the uterus may also be flexed backwards in a retroverted uterus.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b3850989856740139f18dcdc0a181b17x1280x2450.JPEG\" alt=\"Explanation Image\"><p>The angle of anteversion: The angle between the <strong>cervix and vagina. </strong>Normally it is<strong> 90 degrees. </strong>(Remember: V for version, V for vagina)</p>\n<p>The angle of anteflexion: The angle between <strong>cervix and uterus.</strong><strong> </strong>The angle is at the level of the internal os and is 120 degrees.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a2abc9c5bfe446739364959735fbc873x1280x1921.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0042",
      "difficulty": "medium"
    },
    {
      "text": "A 47-year-old P1L1 lady presented with complaints of excessive bleeding during menstruation, and a feeling of heaviness in her lower abdomen. On examination, the uterus appeared enlarged with free adnexa. A hysterectomy was performed and the histopathological slide is shown below.  Which is the most common type of this lesion?",
      "choices": [
        {
          "id": 1,
          "text": "Intramural"
        },
        {
          "id": 2,
          "text": "Subserosal"
        },
        {
          "id": 3,
          "text": "Submucous"
        },
        {
          "id": 4,
          "text": "Extrauterine"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The clinical vignette of excessive menstrual bleeding, heaviness, and the enlarged uterus is suggestive of&nbsp;<strong>leiomyoma.</strong>&nbsp;The <strong>most common</strong> type is&nbsp;<strong>intramural leiomyoma.</strong> The stained histopathological image shows interlacing bundles of uniform <strong>spindle-shaped smooth muscle</strong> cells with blunted nuclei.</p>\n<p>Leiomyomas are benign uterine neoplasms, which are also known as myomas or fibroids. They are classified based on their location as:</p>\n<ul>\n<li><strong>Intramural or interstitial</strong> -most common, grows within the myometrial wall</li>\n<li><strong>Submucous</strong>- grows in the myometrium towards the endometrial cavity, and are covered only by a thin layer of endometrium</li>\n<li><strong>Subserous</strong>:&nbsp;grows from uterine serosa outwards towards the peritoneum</li>\n<li>Other locations outside the uterus like&nbsp;the round ligament, the utero-ovarian and uterosacral ligaments, cervix, vagina, and the vulva.</li>\n</ul>\n<p>When the leiomyoma is attached to a stalk, it is known as a <strong>pedunculated leiomyoma</strong>. Subserosal leiomyomas that attach themselves to nearby pelvic structures and derive vascular support are called <strong>parasitic leiomyomas.</strong></p>\n<p>Risk factors for developing fibroids include:</p>\n<ul>\n<li>Increased risk:\n<ul>\n<li>Nulliparous women</li>\n<li>Obesity</li>\n<li>Hyper estrogenic states -endometriosis, endometrial hyperplasia, endometrial carcinoma</li>\n<li>African-American women.</li>\n</ul>\n</li>\n<li>Decreased risk in multiparous women.</li>\n<li>Recent studies have shown no correlation between smoking and leiomyomas</li>\n</ul>\n<p>Most women with leiomyomas are asymptomatic. However, affected women may complain of heavy menstrual bleeding, pain, pressure, or infertility.<br /><br />Treatment:</p>\n<ul>\n<li>Medical therapy: Drugs to reduce the size of the fibroid\n<ul>\n<li>Antiprogesterone &ndash; Mifepristone/RU-486</li>\n<li>GnRH analogs</li>\n<li>Agonists &ndash; goserelin, nafarelin</li>\n<li>Antagonists &ndash; cetrorelix, ganirelix</li>\n<li>Levonorgestrel releasing intrauterine system</li>\n<li>Selective progesterone receptor modulator (SPRM&rsquo;s) &ndash; Asoprisnil</li>\n</ul>\n</li>\n<li>Uterine artery embolization</li>\n<li>Myomectomy</li>\n<li>Hysterectomy</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5ea12e5996fe459398ff3f9f37353426.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0047",
      "difficulty": "medium"
    },
    {
      "text": "A 26-year-old woman underwent a Pap test, which showed atypical squamous cells of undetermined significance, as per the Bethesda system of classification. This is the first Pap test she has undergone. What is the next step in management?",
      "choices": [
        {
          "id": 1,
          "text": "Colposcopic biopsy"
        },
        {
          "id": 2,
          "text": "Conization"
        },
        {
          "id": 3,
          "text": "Reflex HPV testing"
        },
        {
          "id": 4,
          "text": "Repeat Pap test in 12 months"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In a 26-year-old woman with a pap test showing <strong>atypical squamous cells of undetermined significance</strong>, the next step is <strong>reflex HPV testing</strong>.</p>\n<p><strong>Reflex HPV testing</strong> refers to HPV testing that is done in<strong> response to </strong>a specific <strong>result</strong> (such as abnormal cytology in this case). It is not performed if cytology is negative.</p>\n<p><strong>Atypical squamous cells </strong>of <strong>undetermined significance</strong> (ASC-US) is the most common cervical<strong> cytologic abnormality</strong>. They represent cells that <strong>suggest squamous intraepithelial lesions</strong> but do not fulfill all the criteria for them. The risk of progression to CIN 2 or 3 is low, but it may occur.</p>\n<p><strong>Management</strong> of ASC-US:</p>\n<ul>\n<li>Women aged <strong>21 to 24 </strong>years: <strong>Repeat cytology</strong> in 1 year. If the repeat Pap test result is abnormal, colposcopy should be done. Reflex HPV can be done in this age group. If the result is negative, they are followed up with cytology.</li>\n<li>Women <strong>25 years and older</strong>: <strong>Reflex HPV testing</strong>.\n<ul>\n<li>Reflex HPV test result is positive: Further evaluation with colposcopy.</li>\n<li>Reflex HPV test result is negative: Follow up with a cotest (HPV test+ cytology) in 3 years.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Bethesda system </strong>of cytology reporting for squamous cell abnormalities:</p>\n<div class=\"page\" title=\"Page 502\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Atypical squamous cells (ASC)\n<ul>\n<li>ASC-US - atypical cells of undetermined significance</li>\n<li>ASC-H - cannot rule out a high-grade lesion</li>\n</ul>\n</li>\n<li>Low-grade squamous intraepithelial lesion (LSIL)- includes CIN I</li>\n<li>High-grade squamous intraepithelial lesion (HSIL)- includes CIN II, III</li>\n<li>Squamous cell carcinoma</li>\n</ul>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Grades of cervical dysplasia</h3><p>A comparison of various naming systems based on cytology (Bethesda) and biopsy (CIN grade)</p>\n<table>\n<tbody>\n<tr>\n<td><strong>WHO grade</strong></td>\n<td><strong>Bethesda</strong></td>\n<td><strong>CIN grade</strong></td>\n<td><strong>Description</strong></td>\n</tr>\n<tr>\n<td>Mild Dysplasia</td>\n<td>LSIL</td>\n<td>CIN I</td>\n<td>Dysplastic cells in basal 1/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Moderate Dysplasia</td>\n<td rowspan=\"3\">HSIL</td>\n<td>CIN II</td>\n<td>Dysplastic cells in basal 2/3 of cervical epithelium</td>\n</tr>\n<tr>\n<td>Severe dysplasia</td>\n<td>CIN III</td>\n<td>Dysplastic cells in &gt;2/3 of the cervical epithelium</td>\n</tr>\n<tr>\n<td>Carcinoma in situ</td>\n<td>Carcinoma in situ</td>\n<td>Dysplastic cells in full-thickness of cervical epithelium but basement membrane is intact</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>LSIL</strong></td>\n<td><strong>HSIL</strong></td>\n</tr>\n<tr>\n<td>Atypia confined to the basal one-third of the epithelium</td>\n<td>Atypia involving upper two-third of the epithelium</td>\n</tr>\n<tr>\n<td>80% of LSILs are associated with high-risk HPVs, mostly HPV-16</td>\n<td>100% of HSILs are associated with high-risk HPVs, mostly HPV-16</td>\n</tr>\n<tr>\n<td>60% regress spontaneously; only 10% progress to HSIL.</td>\n<td>30% regress spontaneously; 10% progress to carcinoma</td>\n</tr>\n<tr>\n<td>Not a premalignant lesion</td>\n<td>Premalignant lesion</td>\n</tr>\n<tr>\n<td>Next step - Colposcopic directed biopsy</td>\n<td>Next step -&nbsp;Colposcopic directed biopsy + Endocervical curettage</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Abbreviations:</p>\n<p>CIN: Cervical Intra-epithelial neoplasia</p>\n<p>LSIL: Low Squamous Intra-epithelial Lesion</p>\n<p>HSIL: High&nbsp;Squamous Intra-epithelial Lesion</p><hr><h3>Related Pearl: Management of CIN</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f5d51f1183f4d35857dd881e7f7f708x1280x1886.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0051",
      "difficulty": "medium"
    },
    {
      "text": "The absence of the SRY gene results in which of the following?",
      "choices": [
        {
          "id": 1,
          "text": "Development of testes"
        },
        {
          "id": 2,
          "text": "Development of ovaries and Mullerian system"
        },
        {
          "id": 3,
          "text": "Regression of testes"
        },
        {
          "id": 4,
          "text": "Regression of Mullerian system"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The absence of the SRY gene results in the development of the <strong>ovaries&nbsp;</strong>and the <strong>Mullerian system</strong>.</p>\n<p>In this situation, the gonads will develop into ovaries and the Mullerian duct will differentiate into the uterus, fallopian tubes, and the upper part of the vagina. The master gene responsible for this is the&nbsp;<strong>WNT4 gene.</strong></p>\n<p>The fate of the Mullerian duct is determined by the presence or absence of the <strong>Y chromosome, </strong>which has a&nbsp;sex-determining region called the&nbsp;<strong>SRY gene.</strong></p>\n<p>If the Y chromosome is present, the protein called <strong>testis determining factor</strong> produced by the SRY gene will lead to the development of testis as the gonads.&nbsp;The&nbsp;<strong>Sertoli cells of the testis</strong>&nbsp;will then<strong>&nbsp;</strong>produce&nbsp;<strong>M&uuml;llerian inhibiting substance&nbsp;</strong>(<strong>MIS</strong>; also known as <strong>Anti-M&uuml;llerian hormone, AMH</strong>) that will cause the M&uuml;llerian ducts to regress.</p>\n<p><strong>Functions of SRY and WNT4:</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>SRY gene</strong></td>\n<td><strong>WNT4 gene</strong></td>\n</tr>\n<tr>\n<td>\n<p>Development of the medullary/testes cords</p>\n</td>\n<td>\n<p>The disappearance of medullary/testes cords</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Formation of the tunica albuginea</p>\n</td>\n<td>\n<p>Failure of formation of tunica albuginea</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Failure of development of cortical/ovarian cords&nbsp;</p>\n</td>\n<td>Development of ovaries with typical cortical cords</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Sexual Differentiation</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/536987446eb543f386274c52bc9e5974x1280x2560.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0054",
      "difficulty": "easy"
    },
    {
      "text": "A couple presented to the infertility clinic as they have been unable to conceive for more than a year. The lady has no abnormalities in her laboratory reports. The semen analysis report of her husband is given below. Which of the following findings indicates a diagnosis of asthenospermia?<div class='question-desc-html'><p>Appearance: Opalescent<br />Volume: 2 mL<br />pH: 7.5<br />Fructose: present<br />Sperm concentration:&nbsp;14 million/mL<br />Morphology: 35% normal<br />Motility: 20% motile<br />No sperm agglutination was seen.</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Morphology- 35% normal"
        },
        {
          "id": 2,
          "text": "Motility- 20% motile"
        },
        {
          "id": 3,
          "text": "Concentration- 14 million/mL"
        },
        {
          "id": 4,
          "text": "Volume- 2 mL"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The semen analysis finding of 20% motility (option B) indicates a diagnosis of <strong>asthenospermia</strong>.</p>\n<p><strong>Asthenospermia </strong>refers to<strong> decreased sperm motility</strong>. Normally, <strong>at least 50%</strong> of them should show <strong>progressive motility.&nbsp;</strong>Causes of asthenospermia include prolonged abstinence, anti-sperm antibodies, a genital tract infection, or varicocele.</p>\n<p>Various semen abnormalities include:</p>\n<div class=\"page\" title=\"Page 470\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>An <strong>acidic pH</strong> or <strong>lack of fructose:</strong> indicates an <strong>obstruction</strong> in the efferent ductal system.</p>\n<p>A <strong>low semen volume</strong> reflects incomplete specimen collection, <strong>short abstinence</strong> interval, <strong>partial</strong> vas deferens <strong>obstruction</strong>, or retrograde ejaculation.</p>\n<p><strong>Oligospermia</strong>&nbsp;is defined by a sperm concentration of&nbsp;<strong>&lt;15 million/mL</strong>,&nbsp;<span>concentrations of &lt;5 million/mL are considered severe oligospermia.</span></p>\n<p><strong>Azoospermia</strong> (absence of sperm in semen) occurs due to outflow tract obstruction as a result of <strong>congenital absence of vas deferens</strong>, infection, <strong>vasectomy</strong>, or non-obstructive causes like <strong>testicular failure</strong>.</p>\n<p><strong>Teratospermia</strong> or teratozoospermia refers to <strong>abnormal sperm morphology</strong>.</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Semen Analysis : WHO Criteria (2022)</h3><p><strong>Criteria, Normal values, Lowest reference limits (in brackets)</strong></p>\n<table>\n<tbody>\n<tr>\n<td><strong>Semen analysis </strong></td>\n<td><strong>Normal reference value and minimal reference (in parenthesis) limit</strong></td>\n</tr>\n<tr>\n<td>Volume</td>\n<td>2ml or more (1.4ml)</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>7.2-7.8</td>\n</tr>\n<tr>\n<td>Viscosity</td>\n<td>Less than 3</td>\n</tr>\n<tr>\n<td>Sperm concentration</td>\n<td>20 million/ml (15 million/ml)</td>\n</tr>\n<tr>\n<td>Total sperm count</td>\n<td>More than 40 million/ejaculate</td>\n</tr>\n<tr>\n<td>Motility</td>\n<td>More than 50% progressive forward motility(Progressive motility = 30%)</td>\n</tr>\n<tr>\n<td>Morphology</td>\n<td>More than 4% normal form (lower reference limit)</td>\n</tr>\n<tr>\n<td>Forward progression</td>\n<td>&gt;2 (Scale of 0-4)</td>\n</tr>\n<tr>\n<td>Viability</td>\n<td>54% or more living</td>\n</tr>\n<tr>\n<td>Leucocytes</td>\n<td>Less than 1 million/ml</td>\n</tr>\n<tr>\n<td>Round cells</td>\n<td>Less than 5 million/ml</td>\n</tr>\n<tr>\n<td>Sperm agglutination</td>\n<td>Less than 10 spermatozoa with adherent particles (&lt;2)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0072",
      "difficulty": "easy"
    },
    {
      "text": "An 18-year-old patient presents to the gynecology department with complaints of amenorrhea.  She had no history of cyclical abdominal pain, hormonal intake, radiation or chemotherapy, or any central nervous symptoms like visual disturbances or headaches. After a thorough physical examination, ultrasonography, karyotyping, and diagnostic laparoscopy, the diagnosis of Swyer syndrome was made. Which of the following is not congruent with the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "45 XO karyotype"
        },
        {
          "id": 2,
          "text": "Normal prepubertal female phenotype"
        },
        {
          "id": 3,
          "text": "Normal development of the Mullerian system"
        },
        {
          "id": 4,
          "text": "Presence of dysgenetic testes"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The karyotype of patients with<strong>&nbsp;Swyer syndrome (pure gonadal dysgenesis) </strong>is<strong> 46XY. </strong>The<strong>&nbsp;</strong>45XO karyotype is seen in Turner's syndrome.</p>\n<p>Swyer's syndrome or pure gonadal dysgenesis occurs as a result of a mutation in the <em>SRY</em> gene or another gene with a testis-determining effect such as <em>DAX1</em>, <em>SF-1</em>, or <em>CBX2</em>.&nbsp;This leads to <strong>underdeveloped, dysgenetic gonads</strong> that fail to produce androgens or anti-Mullerian hormone (AMH). The following features are seen:&nbsp;</p>\n<ul>\n<li>Normal prepubertal female phenotype- Absent or poorly developed secondary sexual characteristics due to absence of sex hormones.</li>\n<li>Normal M&uuml;llerian system development due to the absence of AMH. (Uterus and cervix present)</li>\n<li>Female external genitalia</li>\n<li>Presence of dysgenetic testes that cannot produce AMH or sex hormones. They have a risk of malignant transformation.</li>\n</ul>\n<p>As there is gonadal dysgenesis in a patient with&nbsp;<strong>46 XY&nbsp;</strong>karyotype, they are actually determined to be males and are a type of <strong>male</strong> <strong>pseudohermaphrodite</strong>. They present with female external genitalia, primary amenorrhea, and absence of secondary sex characters.</p>\n<p>Points to be considered while treating these patients:</p>\n<ul>\n<li>Cyclical estrogen and progesterone <strong>can induce</strong> <strong>menstruation</strong></li>\n<li>As they have a normal uterus,<strong> pregnancy is possible</strong> through <strong>in vitro fertilization</strong> using a <strong>donor egg.</strong></li>\n<li>Streak gonads may undergo malignant transformation and develop into germ cell tumors. Hence, they have to be removed prophylactically.</li>\n<li><strong>Hormonal replacement therapy</strong> also has a role in maintaining the <strong>bone health</strong> of these patients</li>\n<li>Genetic counseling has to be offered to the affected individuals and their family members.</li>\n</ul>\n<p>&nbsp;</p><hr><h3>Related Pearl: Disorders of Sexual Development</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Disorder</strong></p>\n</td>\n<td>\n<p><strong>Complete androgen insensitivity</strong></p>\n</td>\n<td>\n<p><strong>Mullerian agenesis</strong></p>\n</td>\n<td>\n<p><strong>Turner syndrome</strong></p>\n</td>\n<td>\n<p><strong>Complete XY dysgenesis (Swyer syndrome)</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Cause</strong></p>\n</td>\n<td>\n<p>X-linked mutation of androgen receptor</p>\n</td>\n<td>\n<p>Hypoplastic or absent Mullerian ductal system</p>\n<p><strong>Also called Mayer-Rokitansky-K&uuml;ster-Hauser&nbsp;syndrome</strong></p>\n</td>\n<td>\n<p>Complete or partial absence of one X chromosome</p>\n</td>\n<td>\n<p>SRY gene mutation on the Y chromosome</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Reproductive organs</strong></p>\n</td>\n<td>\n<p>Absent uterus and upper vagina, cryptorchid testis</p>\n</td>\n<td>\n<p>Absent or rudimentary uterus and upper vagina, normal ovaries</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n<td>\n<p>Normal uterus and vagina, streak gonads</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Breast</strong></p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Yes</p>\n</td>\n<td>\n<p>Variable</p>\n</td>\n<td>\n<p>No</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Axillary/</strong><strong>Pubic hair</strong></p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Normal</p>\n</td>\n<td>\n<p>Minimal to absent</p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Karyotype</strong></p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n<td>\n<p>46 XX</p>\n</td>\n<td>\n<p>45 XO or&nbsp;</p>\n<p>45 X mosaicism</p>\n</td>\n<td>\n<p>46 XY</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Note:&nbsp;</p>\n<p>Turner's syndrome have different chromosomal anomalies:</p>\n<ul>\n<li>45 XO which is seen in 40-50% patients&nbsp;</li>\n<li>45 X mosaicism (eg,&nbsp;<span class=\"nowrap\">45,X/46,XX&nbsp;</span>or&nbsp;<span class=\"nowrap\">45,X/47,XXX,</span>&nbsp;or 45,X mosaics with the X chromosome anomalies)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0069",
      "difficulty": "easy"
    },
    {
      "text": "A 50-year-old woman presented to her gynecologist with postcoital bleeding and was diagnosed as a case of carcinoma cervix stage IA1 after evaluation. She was treated with a modified radical hysterectomy. Which of the following structures are not removed?",
      "choices": [
        {
          "id": 1,
          "text": "Proximal  of vagina"
        },
        {
          "id": 2,
          "text": "Uterus"
        },
        {
          "id": 3,
          "text": "Uterine vessels"
        },
        {
          "id": 4,
          "text": "Cervix"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In modified radical hysterectomy/Type II hysterectomy, the<strong> uterine vessels </strong>are <strong>not removed. </strong>They are ligated at the level of the ureter.&nbsp;</p>\n<p>Structures removed in Type II hysterectomy:</p>\n<ul>\n<li><strong>Uterus</strong></li>\n<li><strong>Cervix</strong></li>\n<li><strong>Proximal 1-2cm of the vagina</strong></li>\n<li>Parametrial and paracervical tissue medial to the ureter</li>\n<li>Pelvic nodes</li>\n</ul>\n<p>Indications:</p>\n<ul>\n<li>Stage I A1 cervical cancer with positive margins following conization, but have insufficient cervix to repeat conization.</li>\n<li>Stage I A1 with lymphovascular space invasion</li>\n<li>Stage I A2 cervical cancer</li>\n<li>Occasionally, it may be performed in\n<ul>\n<li>Preinvasive or micro-invasive disease when a more invasive lesion cannot be excluded</li>\n<li>Selected stage IB1 disease with &lt; 2 cm lesion</li>\n<li>Small central post-irradiation recurrences</li>\n</ul>\n</li>\n</ul><p>Main differences between a modified radical hysterectomy (type II) and radical hysterectomy (type III):</p>\n<table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Modified radical hysterectomy</strong></td>\n<td><strong>Radical hysterectomy</strong></td>\n</tr>\n<tr>\n<td><strong>Uterine artery</strong></td>\n<td>Ligated at the level that it crosses the ureters</td>\n<td>Ligated at the origin from the internal iliac artery</td>\n</tr>\n<tr>\n<td><strong>Cardinal ligaments</strong></td>\n<td>Medial half of cardinal ligaments resected</td>\n<td>Cardinal ligaments divided at the sidewall</td>\n</tr>\n<tr>\n<td><strong>Uterosacral ligament</strong></td>\n<td>&nbsp;Divided midway between uterus and sacrum</td>\n<td>Divided at sacrum</td>\n</tr>\n<tr>\n<td><strong>&nbsp;Vagina</strong></td>\n<td>1-2cm of proximal vagina removed</td>\n<td>&gt;2cm of upper vagina removed</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: General treatment for primary invasive cervical carcinoma</h3><table>\n<tbody>\n<tr>\n<td><strong>Stages</strong></td>\n<td><strong>Fertility preserved</strong></td>\n<td><strong>Fertility not preserved</strong></td>\n</tr>\n<tr>\n<td>IA1</td>\n<td>Cervical conization</td>\n<td>Simple hysterectomy</td>\n</tr>\n<tr>\n<td>IA1 (LVSI)</td>\n<td>Radical trachelectomy and pelvic lymphadenectomy</td>\n<td>Modified radical hysterectomy and pelvic lymphadenectomy</td>\n</tr>\n<tr>\n<td>IA2</td>\n<td>\n<p>1. Cervical conization with extraperitoneal pelvic lymphadenectomy</p>\n<p>2. Radical trachelectomy and pelvic lymphadenectomy</p>\n</td>\n<td>Modified Radical hysterectomy and pelvic lymphadenectomy</td>\n</tr>\n<tr>\n<td>\n<p>IB1</p>\n<p>Some IB2, IIA1</p>\n</td>\n<td>Radical trachelectomy and pelvic lymphadenectomy (or)chemoradiation</td>\n<td>Radical hysterectomy and pelvic lymphadenectomy (or) chemoradiation</td>\n</tr>\n<tr>\n<td>Bulky IB3, IIA2</td>\n<td colspan=\"2\">Chemoradiation</td>\n</tr>\n<tr>\n<td>IIB to IVA</td>\n<td colspan=\"2\">Chemoradiation or pelvic exenteration&nbsp;</td>\n</tr>\n<tr>\n<td>IVB</td>\n<td colspan=\"2\">Palliative chemotherapy or palliative radiotherapy or supportive care</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0083",
      "difficulty": "medium"
    },
    {
      "text": "A 46-year old lady is being evaluated for abnormal uterine bleeding by a dilatation and curettage procedure. The following instruments are placed on a table in the minor operating theatre. Which of the following instruments will be used in this procedure?",
      "choices": [
        {
          "id": 1,
          "text": "1, 2 and 3"
        },
        {
          "id": 2,
          "text": "1, 4, 5 and 6"
        },
        {
          "id": 3,
          "text": "2, 3 and 6"
        },
        {
          "id": 4,
          "text": "1, 2, 3, and 4"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Among the given instruments&nbsp;<strong>1, 2, and 3 -</strong>&nbsp;<strong>Sim's uterine curette, Hegar's dilators, and Simpson's uterine sound</strong>&nbsp;are used for dilatation and curettage (D&amp;C).</p>\n<p>Instruments used in D&amp;C:</p>\n<ul>\n<li>Sim&rsquo;s speculum: It retracts the posterior vaginal wall to expose the cervix</li>\n<li>Anterior vaginal wall retractor: Retracts the anterior vaginal wall to expose the cervix.</li>\n<li>Vulsellum or Allis forceps: To hold the anterior lip of the cervix</li>\n<li>Uterine sound:&nbsp;Simpson's uterine sound is a 30 cm long angulated instrument with a handle at one end and a rounded blunt tip at the other.<br />It is used to measure the length of the uterus. It can be identified by the markings used for measurement</li>\n<li>Cervical dilators:&nbsp;\n<ul>\n<li>Hegar's dilator is a<strong>&nbsp;</strong>double-ended dilator used to dilate the cervix.</li>\n<li>Hawkins&rsquo; single-ended dilator&nbsp;</li>\n<li>Fenton&rsquo;s dilator</li>\n</ul>\n</li>\n<li>Curette:\n<ul>\n<li>Sim's curette is a single-ended curette</li>\n<li>Blake's curette is a double-ended curette</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/44a1e2eab77443b99fff1bce6a4f6440x1280x4487.JPEG\" alt=\"Explanation Image\"><p>Other options:&nbsp;</p>\n<p>Karman's cannula: It is used for menstrual regulation.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ef151151c4164a2292946ce1d95d3b1cx1279x791.JPEG\" alt=\"Explanation Image\"><p>Leech Wilkinson's cannula and Rubin's cannula are used in hysterosalpingography.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/eb26972d93e748f8926940f3a5db6dd9x1280x796.JPEG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/84d0add3c01945aebd771354e227b12cx1280x796.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Instruments in OBG</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/59138be1e8d141fe9ebaef4f7e659432x1181x870.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/733db2f903e2492a86c5426c9474709bx1280x938.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1d44522851ed42ec8da170d61c415f12x1159x933.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8cbd2117a78e4c31a4487cddaa43a2c2x871x617.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6d38c784ac734fa3ace7fd390520778ax880x699.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/47aee7f73b87421a9faa3402828666bfx953x721.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/072c8ca058fd4f4d92e6ae299cfdbd04x735x592.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/05dc8444e062403f8c826a7ad52c00d9x759x574.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f40b790592224b05ac1d680696b5c5bcx806x609.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2af70bdfbb4f4253992b9813d001f51dx800x600.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/42a06419caad4e8bb379998dfc73f30cx953x691.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1260a318cf0049718c5175a47f084400x855x654.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/46a8dbc68e894ba8b91d4c14d19b515ex771x677.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4b753a73ddde4ea2acc7c461fb7292a8x762x739.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/26a35cac6bd747bf957fed883a1fd850x922x638.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/91c0754e8b4846c0a6325cbf2e4f8721x1203x701.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/12052a1ae2a64be6937c40bbc4009652x750x705.JPEG\" alt=\"Pearl Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/716cd14aacba4551ae2b97dae6d46352.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0096",
      "difficulty": "medium"
    },
    {
      "text": "A woman was diagnosed with Stage 3 gestational trophoblastic neoplasia as per the classification by the International Federation of Gynecology and Obstetrics (FIGO). Which of the following images represents her stage?",
      "choices": [
        {
          "id": 1,
          "text": "Image 1"
        },
        {
          "id": 2,
          "text": "Image 2"
        },
        {
          "id": 3,
          "text": "Image 3"
        },
        {
          "id": 4,
          "text": "Image 4"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>According to the International Federation of Gynecology and Obstetrics (FIGO), metastases to<strong> lungs</strong> are considered&nbsp;<strong>stage III gestational trophoblastic neoplasia(GTN), </strong>represented by<strong> image 3.</strong></p>\n<table>\n<tbody>\n<tr>\n<td>FIGO Stage&nbsp;</td>\n<td>Extent</td>\n</tr>\n<tr>\n<td>Stage I&nbsp;&nbsp;</td>\n<td>GTN confined to the uterus</td>\n</tr>\n<tr>\n<td>\n<p>Stage II&nbsp;</p>\n</td>\n<td>GTN extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament)</td>\n</tr>\n<tr>\n<td>Stage III&nbsp;</td>\n<td>GTN extends to the lungs, with or without known genital tract involvement</td>\n</tr>\n<tr>\n<td>Stage IV&nbsp;</td>\n<td>All other metastatic sites</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>\n<p>Gestational trophoblastic neoplasia (GTN) refers to the&nbsp;aggressive invasion of the endometrium and myometrium by trophoblast cells. It includes <strong>invasive mole, gestational choriocarcinoma, placental site trophoblastic tumors, and epithelioid trophoblastic tumors.</strong>&nbsp;GTN is diagnosed based on elevated &beta;-hCG levels. FIGO criteria for diagnosis of GTN:</p>\n<ul>\n<li>Persistence of <strong>&beta;-hCG level</strong> <strong>plateau</strong> in <strong>4 measurements</strong> for 3 weeks or longer</li>\n<li><strong>Rise</strong> in <strong>&beta;-hCG</strong> levels in<strong> 3 or more consecutive</strong> measurements done <strong>weekly</strong>, over a period of 2 weeks or longer</li>\n<li><strong>Elevated</strong> <strong>&beta;-hCG level</strong> for <strong>6 months</strong> or more</li>\n<li>Histologic diagnosis of <strong>choriocarcinoma</strong>&nbsp;</li>\n</ul>\n<div class=\"page\" title=\"Page 814\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A modified prognostic scoring system by the WHO distinguishes patients at low risk for therapeutic failure from those at high risk. Treatment for the <strong>low-risk disease</strong> is <strong>chemotherapy</strong> with <strong>methotrexate</strong>, while those with <strong>high-risk disease</strong> are treated with <strong>etoposide, methotrexate, </strong>and<strong> dactinomycin</strong> alternating with <strong>cyclophosphamide</strong> and <strong>vincristine</strong> (EMA/CO) chemotherapy.</p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c7202c49bf54427d98240d2f5177376fx1280x2253.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/279886ed200f47d0aa4f35d494021ef5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0092",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year old lady came to the gynecology outpatient department with complaints of foul-smelling, frothy vaginal discharge. A fresh sample of the discharge is taken and 10 percent potassium hydroxide is added to it. This releases a strong fishy odor. Which of the following conditions can be the etiology of the discharge?<div class='question-desc-html'><ol>\n<li>Candidiasis</li>\n<li>Trichomonas vaginalis</li>\n<li>Bacterial vaginosis</li>\n<li>Chlamydia</li>\n<li>Gonorrhea </li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2 and 3"
        },
        {
          "id": 2,
          "text": "1, 2 and 3"
        },
        {
          "id": 3,
          "text": "3 and 4"
        },
        {
          "id": 4,
          "text": "1, 4 and 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct answer is <strong>2 and 3.</strong></p>\n<p>The test described is the <strong>Whiff test</strong>, which is <strong>positive</strong> in <strong>Trichomonas vaginalis</strong> infections and <strong>bacterial vaginosis</strong>.</p>\n<p>The <strong>whiff test</strong> is performed by the addition of 10 percent <strong>potassium hydroxide</strong> (KOH) to a fresh sample of vaginal secretions. In a positive test, it releases volatile amines that have a <strong>fishy odo</strong>r. With bacterial vaginosis, the <strong>vaginal pH is &gt; 4.5</strong>, as a result of diminished acid production by bacteria. Trichomonas vaginalis infection is also associated with <strong>anaerobic overgrowth</strong> and the production of amines. Thus, women diagnosed with bacterial vaginosis should have no microscopic evidence of trichomoniasis.</p><p><strong>Bacterial vaginosis</strong> is caused by an alteration in the normal vaginal flora, where a decrease in the number of lactobacilli leads to an increase in the number of other organisms like Hemophilus vaginalis, Gardnerella, Mobiluncus, and Mycoplasma hominis. It is diagnosed using Amsel's criteria, where <strong>at</strong> <strong>least three</strong> of the four following criteria should be present to confirm the diagnosis:</p>\n<ul>\n<li>Homogenous vaginal discharge</li>\n<li>Vaginal pH &gt; 4.5</li>\n<li>Amine like odor on adding KOH (Whiff test positive)</li>\n<li>Clue cells (&gt;20% of cells)</li>\n</ul>\n<p>The presence of both clue cells and a positive Whiff test result is pathognomonic of bacterial vaginosis, even if asymptomatic. It is treated with 500 mg of metronidazole twice daily for 7 days.</p>\n<p><strong>Trichomonas vaginalis</strong> is an infection of the female genital tract with the Trichomonas vaginalis protozoan. It characteristically causes a copious, frothy, offensive yellow-green discharge with vaginal soreness or irritation and urinary frequency. On examination, the vagina looks red and inflamed. The inflamed <strong>cervix looks like a strawberry</strong> with punctate hemorrhagic spots.</p>\n<p>It is treated with metronidazole 2 g orally in a single dose (Standard treatment) or tinidazole 2 g orally in a single dose.</p><hr><h3>Related Pearl: Vaginal infections</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bacterial vaginosis</strong></td>\n<td><strong>Trichomonas vaginitis</strong></td>\n<td>\n<p><strong>Candidal vaginitis</strong></p>\n</td>\n</tr>\n<tr>\n<td>Causative organism&nbsp;</td>\n<td>Altered vaginal flora- increased concentration of <strong><em>Gardnerella vaginalis</em></strong></td>\n<td><strong><em>Trichomonas vaginalis</em></strong></td>\n<td><strong><em>Candida albicans</em></strong></td>\n</tr>\n<tr>\n<td>Aetiology</td>\n<td>Increased vaginal pH</td>\n<td>Sexually transmitted</td>\n<td>Decreased immunity</td>\n</tr>\n<tr>\n<td>Sexual transmission</td>\n<td>No</td>\n<td>Yes</td>\n<td>No</td>\n</tr>\n<tr>\n<td>Discharge</td>\n<td>Fishy, thin, yellow</td>\n<td>Frothy, green</td>\n<td>Curdy, white</td>\n</tr>\n<tr>\n<td>Symptoms</td>\n<td>Fishy odour, no itching</td>\n<td>Itching and burning</td>\n<td>Itching, burning</td>\n</tr>\n<tr>\n<td>pH</td>\n<td>&gt;4.5</td>\n<td>&gt;4.5</td>\n<td>&lt;4.5</td>\n</tr>\n<tr>\n<td>Speculum</td>\n<td>No vaginal epithelium inflammation</td>\n<td>Strawberry cervix</td>\n<td>Inflamed-epithelium</td>\n</tr>\n<tr>\n<td>KOH</td>\n<td>Positive Whiff test</td>\n<td>The whiff test can be positive.</td>\n<td>Pseudohyphae seen.</td>\n</tr>\n<tr>\n<td>Wet mount</td>\n<td>Clue cells. No WBCs seen</td>\n<td>Motile trichomaonads, WBCs seen</td>\n<td>WBCs seen</td>\n</tr>\n<tr>\n<td>Treatment</td>\n<td>Metronidazole or Clindamycin</td>\n<td>Metronidazole, treat&nbsp;partner also</td>\n<td>Oral or vaginal azole, no need to treat partner.</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0087",
      "difficulty": "medium"
    },
    {
      "text": "A 25-year-old overweight woman presents with complaints of irregular periods for the last year. Physical examination revealed a BMI of 32 kg/m2 with signs of hirsutism. Pelvic sonographic findings show multiple ovarian follicles arranged in a necklace pattern. Which of the following drugs cannot be used in the treatment of this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Letrozole"
        },
        {
          "id": 2,
          "text": "Finasteride"
        },
        {
          "id": 3,
          "text": "Centchroman"
        },
        {
          "id": 4,
          "text": "Cyproterone acetate"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\">The clinical scenario suggests a diagnosis of <strong>polycystic ovarian disease </strong>(PCOD).&nbsp;<strong>Centrochroman</strong> is not used in the treatment of PCOD.&nbsp;<br /><br />PCOD is attributed to obesity, smoking, and poor diet. The affected ovary or ovaries have cysts (12 or more) that are composed of atretic follicles, coupled with theca and stromal cell hyperplasia.&nbsp;&nbsp;</span></p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\">Symptoms of PCOD include hirsutism and acne (due to hyperandrogenism), anovulation followed by amenorrhea, or heavy menstrual or intermenstrual bleeding.</span></p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\">Diagnosis is made by pelvic&nbsp;<strong>ultrasound</strong> which shows <strong>\"necklace\"</strong> appearance. Endomtrial hyperplasia may also be present.&nbsp;</span></p>\n<p><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\">Treatment of PCOD includes l</span><span data-sheets-value=\"{&quot;1&quot;:2,&quot;2&quot;:&quot;Ulipristal&quot;}\" data-sheets-userformat=\"{&quot;2&quot;:16897,&quot;3&quot;:{&quot;1&quot;:0},&quot;12&quot;:0,&quot;17&quot;:1}\">ifestyle modification such as smoking cessation, diet, and exercise with a focus on weight reduction, c</span>ombined oral contraceptives to regularize menstrual cycles and decrease androgen levels.&nbsp;</p>\n<p>To treat hirsutism, 5&alpha;-reductase inhibitors like <strong>finasteride </strong>are effective;&nbsp;<strong>eflornithine hydrochloride</strong> cream prevents hair growth.<br />&nbsp;<br />Clomiphene is the first line of treatment for women with infertility. It may be combined with dexamethasone to improve the fertility rate.</p>\n<p>Metformin treats the root cause of PCOS, rectifies endocrine and metabolic functions, and improves the fertility rate. It is used as an insulin sensitizer and induces spontaneous ovulation.</p>\n<p>Surgery is indicated when <strong>medical therapy fails</strong>, when there is a history of&nbsp;<strong>previous pregnancy losses</strong>, when there is infertility, or when hyperstimulation occurs. Surgery comprises of laparoscopic<span class=\"Apple-converted-space\">&nbsp;ovarian drilling of not more than 4 cysts in each ovary by laser or unipolar electric cautery. It improves fertility for a period of one year.&nbsp;</span></p><hr><h3>Related Pearl: Management of PCOD</h3><table>\n<tbody>\n<tr>\n<td><strong>Complaint</strong></td>\n<td><strong>Management</strong> &nbsp;</td>\n</tr>\n<tr>\n<td>Irregular periods</td>\n<td>OCPs</td>\n</tr>\n<tr>\n<td>Obesity</td>\n<td>Lifestyle modification</td>\n</tr>\n<tr>\n<td>Insulin resistance</td>\n<td>Metformin</td>\n</tr>\n<tr>\n<td>Hirsutism /acne</td>\n<td>OCPs with cyproterone acetate</td>\n</tr>\n<tr>\n<td>Infertility</td>\n<td>Clomiphene</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Note: Letrozole is as effective as Clomiphene in treating infertility in PCOD with fewer side effects. However, it's pending FDA approval and is used off-label.</p><hr><h3>Related Pearl: Endocrinological changes of PCOD</h3><ol>\n<li>Elevated Estrone/E1 levels.</li>\n<li>LH level is raised over 10 IU/mL. FSH level remains normal to low, but<strong> FSH/LH ratio falls.</strong></li>\n<li>Testosterone and epi-androstenedione levels rise.<br />\n<ul>\n<li><strong>Testosterone elevated but &lt; 200 ng/dL </strong>(normal range 20 -80 ng/dL)</li>\n<li>Testosterone &gt; 200 ng/dL suggests androgen-secreting ovarian tumor</li>\n<li>DHEA-S values may be normal or slightly elevated</li>\n<li>DHEA &gt;700 ng/mL suggests adrenal tumour</li>\n</ul>\n</li>\n<li>Serum SHBG is reduced.</li>\n<li><strong>Triglyceride level &gt;150 mg/dL</strong>-hyperlipidaemia HDL &lt;50 mg/dL.</li>\n<li>Fasting blood glucose/fasting insulin &lt;4.5 suggests insulin resistance</li>\n<li>Prolactin is mildly raised in 15% cases</li>\n<li><strong>Fasting insulin is more than 10 mIU/L in PCOS in 50–70%cases</strong></li>\n<li>Thyroid function tests may be abnormal (hypothyroidism)</li>\n<li>17-a-hydroxyprogesterone in the follicular phase &gt;300 ng/dL suggests adrenal hyperplasia due to 21-hydroxylase deficiency.</li>\n<li><strong>Urinary cortisol &lt;50 μg/24 h.</strong></li>\n</ol>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0123",
      "difficulty": "medium"
    },
    {
      "text": "You are a gynecologist with a special interest in hormone replacement therapy (HRT). Among the following patients, to whom would you avoid prescribing HRT?<div class='question-desc-html'><ol>\n<li>A 35-year-old woman who has undergone total abdominal hysterectomy+bilateral salpingo-oophorectomy</li>\n<li>A 65-year-old woman having hot flushes with undiagnosed vaginal bleeding</li>\n<li>A 57-year-old woman having hot flushes and risk factors for developing osteoporosis</li>\n<li>A 62-year-old woman with atrophic vaginitis and a history of myocardial infarction 10 months ago</li>\n<li>A 52-year-old woman with irritability and hot flushes, with a history of deep vein thrombosis in her previous pregnancy.</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 4, 5"
        },
        {
          "id": 2,
          "text": "1, 2, 3"
        },
        {
          "id": 3,
          "text": "1, 3, 4"
        },
        {
          "id": 4,
          "text": "2, 3, 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>Hormone replacement therapy (HRT) is contraindicated in cases <strong>2, 4, and 5.</strong></p>\n<p>HRT involves the cyclical administration of estrogen and progesterone, where estrogen is administered for 25 days followed by a progestin for 10-12 days. Re-evaluation for further need for HRT is done every 6-12 months. The progestin is added to lower the risk of developing endometrial cancer.</p>\n<p><strong>Contraindications </strong>for HRT<strong>:</strong></p>\n<ul>\n<li>Undiagnosed abnormal bleeding from the genital tract</li>\n<li>Known, suspected, or history of breast cancer, or&nbsp;estrogen-dependent neoplasias</li>\n<li>Active or previous history venous thromboembolism</li>\n<li>Active or recent (e.g., within the past year) arterial thromboembolic diseases such as stroke or myocardial infarction</li>\n<li>Liver or gall bladder disease</li>\n<li>Known hypersensitivity to the ingredients of HRT</li>\n<li>Known or suspected pregnancy</li>\n</ul>\n<p><strong>Indications for HRT:</strong></p>\n<ul>\n<li>Therapeutic:\n<ul>\n<li>Symptomatic women who suffer from estrogen deficiency- vasomotor symptoms, vaginal atrophy</li>\n<li>Gonadal dysgenesis in adolescents</li>\n</ul>\n</li>\n<li>Prophylactic: High-risk cases for menopausal complications such as\n<ul>\n<li>Cardiovascular disease, osteoporosis, Alzheimer&rsquo;s disease, and colonic cancer</li>\n<li>Premature menopause following hysterectomy, tubectomy, radiotherapy, chemotherapy.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0133",
      "difficulty": "easy"
    },
    {
      "text": "An elderly woman presented with a 6-month history of a non-healing genital ulcer. Examination revealed a solitary ulcer measuring 3cm x 2cm on the labia majora. No lymph nodes were palpable. Biopsy revealed nests of malignant squamous epithelium with prominent central keratin pearls surrounded by a chronic inflammatory infiltrate. Which of the following is not considered a risk factor for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Age >70 years"
        },
        {
          "id": 2,
          "text": "HPV 11 infection"
        },
        {
          "id": 3,
          "text": "Lichen sclerosus"
        },
        {
          "id": 4,
          "text": "Chronic immunosuppression"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The clinical vignette is suggestive of <strong>squamous carcinoma of the vulva</strong>, and HPV 11 infection is not considered a risk factor.</p>\n<p>Infection with <strong>HPV types 16, 18, 31, 33, and 45</strong> are known to be associated with the risk of the development of vulvar carcinoma. <strong>HPV 16</strong> infection is the <strong>most common</strong>. <strong>HPV 6 and 11</strong> cause most cases of <strong>genital warts</strong> but are seldom linked to cancer and are known as low-risk HPV.</p>\n<p><strong>Squamous cell carcinoma</strong> is the <strong>most frequent</strong> vulvar carcinoma, followed by malignant melanoma. Patients present with pruritis and a visible lesion that may be ulcerated, bleeding, warty, raised, or pigmented. There may be other clinical entities, such as preinvasive neoplasia (vulval intraepithelial neoplasia -<em> </em>VIN), infection, chronic inflammatory disease, and granulomatous disease.</p>\n<p>On histopathological examination, the tumor shows classic features of invasive squamous cell carcinoma, such as squamous cells, intercellular bridges, and eosinophilic keratin pearls. Nests of invasive tumor cells are surrounded by chronic inflammation.</p>\n<p>Risk factors for vulvar carcinoma: </p>\n<ul>\n<li><strong>Age</strong>: The risk of vulvar cancer <strong>increases with age;</strong> the highest incidence is seen in women over 70 years of age.</li>\n<li>Human papillomavirus (HPV)- <strong>HPV 16</strong> is the <strong>most commonly</strong> associated type, but HPV types 18, 31, 33, and 45 are also known risk factors.</li>\n<li>HSV infection (usually in a smoker)</li>\n<li>Smoking</li>\n<li><strong>Chronic immunosuppression</strong> - HIV infection, transplantation patients</li>\n<li><strong>Lichen sclerosus</strong>- chronic vulvar inflammatory disease and can be considered a precursor lesion, usually in older women</li>\n<li>Other genital cancers: Women with cervical cancer might have a higher risk of vulvar cancer  </li>\n<li>Progression from VIN</li>\n</ul>\n<p>The images below show Stages IA, IB, 2, 3, 4A, and 4B of vulvar carcinoma in order:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/00666c49c9ed4cc6bbdffc157d83f89fx1024x523.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/66d537ccaaa54e9ebc1e28f641397893x766x542.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/c3a248b8b9214e87998ec200cf13870dx1280x614.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6226a17092c84c2ba7312957c581f255x800x674.PNG\" alt=\"Explanation Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/dcd982261da04530aab42d30f231a434x800x794.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Treatment Modality in Vulval Cancer</h3><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment </strong></td>\n</tr>\n<tr>\n<td><strong>1A</strong></td>\n<td>\n<ul>\n<li>&nbsp;Radical wide local excision\n<div class=\"layoutArea\">&nbsp;</div>\n</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>1B</strong></td>\n<td>\n<ul>\n<li>Partial vulvectomy + ipsilateral inguinofemoral lymph node dissection</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Tumor 2-4cm &ndash; total vulvectomy + B/L groin lymph node dissection</li>\n<li>Tumor &gt;4cm or poorly differentiated &ndash; radical vulvectomy + B/L lymphadenectomy + pelvic lymph node dissection</li>\n</ul>\n<div class=\"page\" title=\"Page 493\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Megavoltage radiotherapy</li>\n<li>Local surgical excision -&nbsp;Radical vulvectomy + B/L lymphadenectomy + pelvic lymph node dissection</li>\n<li>Local recurrence &ndash; chemotherapy</li>\n</ul>\n<div class=\"page\" title=\"Page 493\">&nbsp;</div>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Chemotherapy or radiotherapy</li>\n<li>Local excision on residual tumor</li>\n<li>ipsilateral inguinofemoral lymph node + ve &ndash; contralateral node removed</li>\n<li>Femoral lymph node +ve &ndash; pelvic lymph node removed</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p><hr><h3>Related Pearl: Staging of Vulval Cancer (FIGO)</h3><table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Features</strong></td>\n</tr>\n<tr>\n<td><strong>I</strong></td>\n<td>Tumor confined to vulva</td>\n</tr>\n<tr>\n<td>IA</td>\n<td>Lesions&nbsp;&le;2 cm in size, confined to the vulva or perineum and with stromal invasion&nbsp;&le; 1 mm, no nodal metastasis</td>\n</tr>\n<tr>\n<td>IB</td>\n<td>Lesions &gt;2cm in size or with stromal invasion &gt;1mm , confined to the vulva or perineum, with negative nodes</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>Tumor of any size with extension to adjacent perineal structures (lower 1/3<sup>rd</sup> urethra, lower 1/3<sup>rd</sup> vagina, anus) with negative nodes</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>Tumor of any size with/without extension to adjacent perineal structures (lower 1/3<sup>rd</sup> urethra, lower 1/3<sup>rd</sup> vagina, anus) with positive inguinofemoral lymph nodes</td>\n</tr>\n<tr>\n<td>IIIA</td>\n<td>i) With 1 lymph node macrometastases (&ge;5mm) or,</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii)1-2 lymph node micrometastases(&lt;5mm)</td>\n</tr>\n<tr>\n<td>IIIB</td>\n<td>i) With 2 or more lymph node macrometastases (&ge;5mm), or</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii) 3 or more lymph node micrometastases (&lt;5 mm)</td>\n</tr>\n<tr>\n<td>IIIC</td>\n<td>With positive nodes with extracapsular spread</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>Tumor invades other regional structures (upper 2/3<sup>rd</sup> urethra, upper 2/3<sup>rd</sup> vagina) or distant structures</td>\n</tr>\n<tr>\n<td>IVA</td>\n<td>Tumour invades any of the following:</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>i) Upper urethral and/or vaginal mucosa, bladder mucosa, rectal mucosa, or fixed to the pelvic bone, or</td>\n</tr>\n<tr>\n<td>&nbsp;</td>\n<td>ii) Fixed or ulcerated inguinofemoral lymph nodes</td>\n</tr>\n<tr>\n<td>IVB</td>\n<td>Any distant metastasis including pelvic lymph nodes</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0126",
      "difficulty": "medium"
    },
    {
      "text": "In a family planning clinic, you see a flyer advertising the pills shown below as a method of contraception. Identify the true statement about it.",
      "choices": [
        {
          "id": 1,
          "text": "Cannot be used during lactation"
        },
        {
          "id": 2,
          "text": "Exacerbates hypertension"
        },
        {
          "id": 3,
          "text": "Can be taken by diabetic women"
        },
        {
          "id": 4,
          "text": "No risk of thromboembolism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<div class=\"page\" title=\"Page 154\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>The true statement about <strong>desogestrel pills</strong> (synthetic progesterone-only pills) is that they&nbsp;<strong>can be taken </strong>by<strong> diabetic women</strong>. This is because&nbsp;they have minimal effects on carbohydrate metabolism.</p>\n<p>Progesterone-only pills are also known as minipills. They are started 21 days <strong>postpartum</strong> and <strong>soon after an abortion</strong>. The woman needs to take precautions in the first 48 hours of the first cycle.</p>\n<p>The mechanism of action of progesterone-only pills involves thickening of the cervical mucus that inhibits penetration of sperms (mainly), atrophy of the endometrium, and inhibition of ovulation.</p>\n<p><strong>Advantages</strong> of progesterone-only pills include:</p>\n<ul>\n<li><strong>Minimal </strong>or<strong> no effects </strong>on<strong> carbohydrate </strong>and<strong> lipid metabolism</strong></li>\n<li>Do<strong> not cause</strong> or <strong>exacerbate hypertension&nbsp;</strong></li>\n<li>Do not impair milk production, therefore <strong>suitable </strong>during <strong>lactation</strong></li>\n<li>Safe for women with a history of migraine headaches</li>\n<li>Safe for smokers who are older than 35 years</li>\n</ul>\n<p>Contraindications include abnormal uterine bleeding, breast cancer, hepatic cancer, pregnancy, and active severe liver disease. Additionally, synthetic progestogens like desogestrel are associated with a <strong>higher incidence</strong> of <strong>thromboembolism</strong>.</p>\n</div>\n</div>\n</div>\n</div><hr><h3>Related Pearl: Hormonal contraceptives</h3><div dir=\"ltr\">\n<p><strong>Oral pills:</strong></p>\n<ul>\n<li>Combined oral contraceptive pills (COC)\n<ul>\n<li>Mala D -&nbsp;Levonorgestrel 0.15 mg + Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate</li>\n<li>Mala N -&nbsp;Levonorgestrel 0.15 mg +&nbsp;Ethinyl estradiol &nbsp;0.03 mg + Ferrous fumarate&nbsp;(Govt. supply, free of cost)</li>\n</ul>\n</li>\n<li>Progesterone only pills (POP) - suitable for lactating women\n<ul>\n<li>Norethisterone 350 &mu;g</li>\n<li>Norgestrel 75 &mu;g</li>\n<li>Levonorgestrel (LNG) 30 &mu;g</li>\n</ul>\n</li>\n<li>Once a month or long-acting pills - highly disappointing results\n<ul>\n<li>Quinestrol (long-acting estrogen) + short-acting progesterone</li>\n</ul>\n</li>\n<li>Gossypol - male pill : Cottonseed derivative and causes azoospermia and severe oligospermia</li>\n<li>Post-coital pills or interceptive\n<ul>\n<li>Levonorgestrel 0.75 mg, 2 doses, 12 hours apart</li>\n<li>Mifepristone 10-600 mg</li>\n<li>Ulipristal 30 mg, within 5 days of intercourse</li>\n<li>Centchroman 60 mg, 2 tablets, within 24 hrs of intercourse</li>\n<li>GnRH agonists &nbsp;</li>\n<li>CuT IUCD, inserted within 5 days</li>\n</ul>\n</li>\n</ul>\n<p><strong> Injectable contraceptives</strong></p>\n<ul>\n<li>Progesterone only injectables\n<ul>\n<li>DMPA&nbsp;150 mg IM every 3 months</li>\n<li>NET-EN&nbsp;200 mg IM every 2 months</li>\n</ul>\n</li>\n<li>Combined injectables\n<ul>\n<li>Cyclofem - DMPA 25 mg + Estradiol cypionate 5 mg</li>\n<li>Mesigyna - NET-EN 50 mg &nbsp;+ Estradiol valerate 5 mg</li>\n</ul>\n</li>\n</ul>\n<p><strong> Subdermal implants</strong></p>\n<ul>\n<li>Norplant I -&nbsp;Levonorgestrel 35 mg</li>\n<li>Norplant II or Jadelle -&nbsp;2 rods with levonorgestrel 70 mg in each and released at a rate of 50 &mu;g/day &nbsp;</li>\n</ul>\n<p><strong>Others</strong></p>\n<ul>\n<li>Hormonal IUCD -&nbsp;Mirena which contains LNG 52 mg with release rate of&nbsp;20 &mu;g/day</li>\n<li>Orthoevra patch -&nbsp;Norelgestomin + Ethinyl estradiol weekly for 3 weeks, then patch free for 1 week</li>\n<li>Vaginal ring or Nuvaring - Etonogestrel + ethinyl estradiol daily release, use for 3 weeks with withdrawal for 1 week</li>\n</ul>\n</div><hr><h3>Related Pearl: Classification Of Contraceptives Based On Effectiveness</h3><table>\n<tbody>\n<tr>\n<td>Category</td>\n<td>Failure rate in first year</td>\n<td>Contraceptive</td>\n</tr>\n<tr>\n<td>First tier</td>\n<td>&nbsp;&lt; 2 %</td>\n<td>IUCD, Implants, Sterilization</td>\n</tr>\n<tr>\n<td>Second tier</td>\n<td>&nbsp;3-9 %</td>\n<td>Hormonal - oral, injected, transdermal patches, transvaginal rings</td>\n</tr>\n<tr>\n<td>Third tier</td>\n<td>&nbsp;10-20 %</td>\n<td>Barrier, Fertility awareness method</td>\n</tr>\n<tr>\n<td>Fourth tier</td>\n<td>&nbsp;21-30 %</td>\n<td>Spermicidal preparations</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Methods of contraceptions</h3><table>\n<tbody>\n<tr>\n<td><strong>Methods</strong></td>\n<td><strong>Advantages</strong></td>\n<td><strong>Disadvantages</strong></td>\n</tr>\n<tr>\n<td><strong>Barrier</strong></td>\n<td>\n<ul>\n<li>Prevents STD, HIV</li>\n<li>The incidence of Ca cervix reduced</li>\n<li>Effective if used properly</li>\n<li>No contraindication use</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Cumbersome</li>\n<li>&nbsp;Coital dependent</li>\n<li>&nbsp;Short term</li>\n<li>&nbsp;High failure rate</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Lactation</strong></td>\n<td>\n<ul>\n<li>Beneficial to the newborn</li>\n<li>Contraceptive action (non-ovulatlon) 6 months</li>\n</ul>\n</td>\n<td>Short-term benefit</td>\n</tr>\n<tr>\n<td><strong>IUCD</strong></td>\n<td>\n<ul>\n<li>Long-term use</li>\n<li>Effective</li>\n<li>Coital Independent</li>\n</ul>\n</td>\n<td>Side effects<br />&bull; Failure rate 1-3%<br />&bull; Contraindicated In few</td>\n</tr>\n<tr>\n<td><strong>Hormones</strong></td>\n<td>Effective 99-100% long-term use of beneficial effects<br />of OC coital independent</td>\n<td>Side effects<br />&bull; Not used during lactation<br />&bull; Contraindicated In few<br />&bull; Requires Surgery for implantation</td>\n</tr>\n<tr>\n<td><strong>Surgery</strong></td>\n<td>Permanent and effective</td>\n<td>Surgical complications surgery required.<br />&bull; Not suited in low parity women</td>\n</tr>\n<tr>\n<td><strong>Postcoital</strong></td>\n<td>Effective 95-98% short-term use</td>\n<td>Failure in 1-5%<br />Not used as contraceptives</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/77721f250e40465098975da73b362c60.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0127",
      "difficulty": "hard"
    },
    {
      "text": "A 20-year old female patient presented with painless lesions on the vulva as shown in the image below. Which of the following vaccines is not protective against this condition?",
      "choices": [
        {
          "id": 1,
          "text": "Gardasil"
        },
        {
          "id": 2,
          "text": "Cervarix"
        },
        {
          "id": 3,
          "text": "Gardasil-9"
        },
        {
          "id": 4,
          "text": "Quadrivalent HPV vaccine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The condition in the image is <strong>condyloma acuminata (venereal warts)</strong> caused by infection with human papilloma virus <strong>6 or 11.</strong> The Cervarix vaccine does not protect against it. <strong>Cervarix</strong> offers protection against HPV subtypes <strong>16,18</strong>, which cause CIN and Ca cervix.</p>\n<p>The image shows <strong>multiple warty growths </strong>on the vulva and around the anal canal, as seen in condyloma acuminata<strong>.</strong> The verrucous growths may appear discrete or coalesce to form large <strong>cauliflower-like </strong>growths. They may be asymptomatic but can also cause discomfort, discharge, or bleeding. Treatment may include <strong>ablation</strong>, <strong>excision</strong>, or <strong>topical agents</strong> such as podophyllin and imiquimod.</p>\n<p>The available vaccinations against HPV are summarized below.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Brand name</strong></td>\n<td><strong>Cervarix</strong></td>\n<td><strong>Gardasil</strong></td>\n<td><strong>Gardasil-9</strong></td>\n</tr>\n<tr>\n<td>Characteristic and HPV subtypes</td>\n<td>Bivalent:16,18</td>\n<td>Quadrivalent: <strong>6,11,</strong>16,18</td>\n<td>Nonavalent: <strong>6,11</strong>,16,18,31,33,45,52,58</td>\n</tr>\n<tr>\n<td>Protects against:</td>\n<td>CIN, Ca cervix</td>\n<td>Anogenital warts, CIN, Ca cervix</td>\n<td>Anogenital warts, CIN, CA cervix,  Vulval intraepithelial neoplasia, Vaginal intraepithelial neoplasia</td>\n</tr>\n<tr>\n<td>Dose</td>\n<td>0.5ml </td>\n<td>0.5ml</td>\n<td>0.5ml</td>\n</tr>\n<tr>\n<td>Administration</td>\n<td>0, 1, 6 months i.m</td>\n<td>0, 2, 6 months i.m</td>\n<td>0, 2, 6months, i.m</td>\n</tr>\n<tr>\n<td>Administered gender</td>\n<td>Female and male</td>\n<td>Female and male</td>\n<td>Female and male</td>\n</tr>\n<tr>\n<td>Ideal Age range:</td>\n<td>11-12 years,9-26 years </td>\n<td>11-12 years, 9-26 years for both male and female</td>\n<td>\n<p>Females:11-12 years, 9-26 years</p>\n<p>Males:11-12 years</p>\n<p>9-15 years - FDA approved</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Gardasil 9</strong> has received expanded indication, which now includes the <strong>prevention of oropharyngeal</strong> and other <strong>head and neck cancers</strong> caused by HPV types 16,18,31,33,45,52,58.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5f392e1762c142ffb4f23324c1097a74.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0128",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old woman is being evaluated for ovulation function. Which of the following is seen after the ovulation has occurred?<div class='question-desc-html'><p>LH- Luteinizing hormone</p></div>",
      "choices": [
        {
          "id": 1,
          "text": "Urinary LH peak"
        },
        {
          "id": 2,
          "text": "Increase in basal body temperature"
        },
        {
          "id": 3,
          "text": "Growth of ovarian follicles seen on USG"
        },
        {
          "id": 4,
          "text": "Ferning of cervical mucus"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>An <strong>increase in basal body temperature</strong> is seen after ovulation has occurred.</p>\n<p>The basal body temperature (BBT)&nbsp;<strong>decreases </strong>by around <strong>1/2&deg;F</strong>&nbsp;at the time of<strong>&nbsp;ovulation</strong> and then <strong>increases by</strong>&nbsp;<strong>1/2-1&deg;F </strong>during the progestational half of the cycle. This occurs due to the <strong>thermogenic action</strong> of the hormone&nbsp;<strong>progesterone</strong>.<strong>&nbsp;</strong>When this is represented graphically,&nbsp;a<strong> biphasic pattern </strong>is observed and is strongly predictive of ovulation, as shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b81780b49b244ae484a41a4bc9f492a3x568x352.JPEG\" alt=\"Explanation Image\"><p>&nbsp;</p>\n<p>However, this method cannot accurately predict ovulation.<strong>&nbsp;</strong>It provides a<strong> retrospective diagnosis of ovulation</strong> and is not useful therapeutically.</p>\n<p>Other options:<br /><br />Option A:&nbsp; <strong>Urinary&nbsp;LH peak&nbsp;</strong>(<strong>increase in LH</strong>) is usually seen<strong>&nbsp;1 day prior to ovulation</strong> and is used to predict the time of ovulation. It is detected by daily monitoring of urinary LH levels and spans for about 48-50 hours.</p>\n<p>Option C: <strong>Growth of ovarian follicles</strong> is seen on USG <strong>prior to ovulation</strong>. The follicle is observed to grow at the rate of <strong>1-2 mm per day</strong> before follicular rupture, and ovulation occurs when it is <strong>20 mm or more</strong> in size. This is a reliable and safe method of predicting ovulation.</p>\n<p>Option D: The appearance&nbsp;of a <strong>fern pattern</strong> is seen <strong>before ovulation</strong>. <strong>After ovulation</strong>, the progesterone thickens the cervical mucus, leading to <strong>the loss of fern pattern</strong>.</p>\n<p><strong>Positive fern test</strong> as seen before ovulation is shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6817c9190e454425aa8883a8b17d1ffax900x1200.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0136",
      "difficulty": "medium"
    },
    {
      "text": "A post-menopausal woman who presented with abnormal uterine bleeding is scheduled for endometrial biopsy. In her case file, you see her transvaginal sonography report. What is the endometrial thickness you are expecting to see?",
      "choices": [
        {
          "id": 1,
          "text": "2 mm"
        },
        {
          "id": 2,
          "text": "0.5 mm"
        },
        {
          "id": 3,
          "text": "3.5 mm"
        },
        {
          "id": 4,
          "text": "6 mm"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>In a <strong>postmenopausal woma</strong>n with <strong>abnormal uterine bleeding</strong>, investigations like <strong>endometrial sampling</strong> is indicated when the<strong> </strong>endometrial <strong>thickness is &gt;4 mm</strong>. Since the patient is posted for an endometrial biopsy, the thickness of her endometrium is likely to be more than 4 mm. </p>\n<table>\n<tbody>\n<tr>\n<td><strong>Timing</strong></td>\n<td><strong>Endometrial thickness</strong></td>\n</tr>\n<tr>\n<td>Immediately after menstruation</td>\n<td>1–2 mm</td>\n</tr>\n<tr>\n<td>Early proliferative phase</td>\n<td>5–7 mm</td>\n</tr>\n<tr>\n<td>Secretory phase</td>\n<td>7–16 mm</td>\n</tr>\n<tr>\n<td>Preovulatory phase </td>\n<td>up to 12 mm</td>\n</tr>\n<tr>\n<td>Postmenopausal (Asymptomatic)</td>\n<td>&lt;4 mm</td>\n</tr>\n<tr>\n<td>Postmenopausal with bleeding; investigations should start when the thickness is</td>\n<td><strong>&gt;4 mm</strong></td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>An endometrial biopsy can be done by</p>\n<ul>\n<li>Dilatation and curettage</li>\n<li>Uterine cavity aspiration using a pipelle and endometrial sampling (office biopsy)</li>\n</ul>\n<p>Indications for endometrial sampling:</p>\n<ul>\n<li>Any <strong>woman aged &gt;45 years with abnormal uterine bleeding</strong></li>\n<li>A woman aged &lt;45 years with <strong>exposure to excessive estrogen</strong>,<strong> </strong>such as those with polycystic ovary disease, severe obesity, or tamoxifen treatment</li>\n<li>Women with failed medical management and persistent bleeding</li>\n<li>Transvaginal ultrasound showing an endometrial thickness of <strong>&gt;12 mm in premenopausal women</strong> and<strong> &gt;4 mm in postmenopausal women</strong></li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0142",
      "difficulty": "medium"
    },
    {
      "text": "In which of the following stages of puberty does estrogen not have a major role?",
      "choices": [
        {
          "id": 1,
          "text": "Pubarche"
        },
        {
          "id": 2,
          "text": "Thelarche"
        },
        {
          "id": 3,
          "text": "Menarche"
        },
        {
          "id": 4,
          "text": "Growth spurt"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Pubarche,</strong> or the <strong>development of pubic hair,</strong> is not mediated by estrogen.</p>\n<p>In both sexes, <strong>adrenal</strong> <strong>androgen </strong>secretion is responsible for adrenarche—the development of axillary and pubic hair. The eventual phenotypical result of adrenarche is pubarche, increased oiliness of hair and skin, and acne.</p>\n<div class=\"page\" title=\"Page 68\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Puberty refers to the period of transition from childhood to adult sexual maturation. On average, puberty typically begins between the ages of 8 and 13 years in females and 9 and 14 years in males. </p>\n<p>The following changes occur in puberty:</p>\n<ul>\n<li><strong>Thelarche</strong> refers to breast development, which signifies the start of puberty in girls. It is due to the action of estrogen and progesterone.</li>\n<li><strong>Pubarche </strong>occurs after thelarche, and refers to the appearance of pubic hair. <strong>Adrenarche</strong> refers to the increased secretion of adrenal androgens which leads to pubarche.</li>\n<li><strong>Growth spurt </strong>occurs due to a rise in sex steroids, which leads to an increase in growth hormone levels and IGF-1.</li>\n<li><strong>Menarche </strong>refers to the beginning of menstruation due to an increase in follicle-stimulating hormone (FSH) and luteinizing hormone (LH).</li>\n</ul>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0146",
      "difficulty": "medium"
    },
    {
      "text": "A young woman was diagnosed with a structural uterine abnormality by hysterosalpingography. Which two anomalies cannot be easily differentiated from each other by this investigation?",
      "choices": [
        {
          "id": 1,
          "text": "Septate and didelphys uterus"
        },
        {
          "id": 2,
          "text": "Didelphys and bicornuate uterus"
        },
        {
          "id": 3,
          "text": "Septate and bicornuate uterus"
        },
        {
          "id": 4,
          "text": "Arcuate and didelphys uterus"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Septate </strong>and<strong> bicornuate uterus </strong>are the two anomalies that cannot be easily differentiated from each other by <strong>hysterosalpingography </strong>(HSG). HSG provides excellent information about the <strong>interior contour</strong> of the uterine cavity, but not the external uterine contour. </p>\n<div class=\"page\" title=\"Page 448\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>A <strong>bicornuate uterus</strong> is characterized by <strong>two separate endometrial cavities</strong>, that may communicate with each other and a single uterine cervix. It is caused by the <strong>incomplete fusion</strong> of the <strong>müllerian ducts</strong>. Failure of fusion may extend to the cervix, resulting in a complete bicornuate uterus, or may be partial, causing a milder abnormality. </p>\n<div class=\"page\" title=\"Page 449\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>On HSG, the bicornuate uterus is seen as widely <strong>diverging horns</strong> with an <strong>intercornual angle &gt;105 degrees</strong>. However, <strong>MR imaging</strong> is necessary to define the <strong>external</strong> or <strong>fundal contour</strong>.</p>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5a9044b912c94d0585fb650def038aefx1245x771.JPEG\" alt=\"Explanation Image\"><p>A <strong>septate uterus</strong> is characterized by the presence of a <strong>septum </strong>in the <strong>endometrial cavity</strong>. It is caused by the <strong>failure</strong> of the <strong>medial segments</strong> of the <strong>müllerian ducts</strong> to <strong>regress</strong>, creating a permanent septum within the uterine cavity. The septum can project minimally from the fundus or can extend completely to the cervical os. </p>\n<p>On HSG, the <strong>intercornual angle</strong> is<strong> &lt;75 degrees </strong>(as shown in the image below). </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/8035f232257648d6a69b6c0ab9a99916x1208x778.JPEG\" alt=\"Explanation Image\"><p>Unfortunately, the <strong>majority</strong> of <strong>angles</strong> of <strong>divergence</strong> between the horns fall between<strong> 75</strong> and <strong>105 degrees</strong> leading to overlapping between the two anomalies on HSG.</p>\n<p><strong>Transvaginal 3D ultrasonography</strong> (3D TV USG) is the <strong>best investigation</strong> to differentiate between the bicornuate uterus and a septate uterus and is recommended for the assessment of patients with a suspected uterine anomaly.</p>\n<p><strong>Pelvic MRI</strong> without contrast also provides excellent delineation of both internal and external uterine contours. It should be reserved for patients in whom 3D TV US is not possible as in the case of <strong>virgins</strong>.</p>\n<p>Other options:</p>\n<p><strong>Uterus Didelphys</strong>: A didelphic uterus is characterized by <strong>two separate uterine horns</strong>, each with an<strong> endometrial cavity </strong>and <strong>cervix</strong>. It results from the failure of the fusion of the paired müllerian ducts.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/01c96d3ecb4241efbd9a47c55a0de83fx608x362.PNG\" alt=\"Explanation Image\"><p><strong>Arcuate uterus</strong>: It is characterised by <strong>minimal fundal cavity indentation</strong> or a slight midline septum within a broad fundus. </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a9d414be624a4bf9a3bd80e53f4d0d65x576x366.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Mullerian Anomalies</h3><div class=\"ng-scope\">\n<div class=\"ng-scope\">\n<p class=\"ng-binding\">&nbsp;</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Class</strong></td>\n<td><strong>Mullerian anomaly</strong></td>\n<td><strong>Reason/Feature</strong></td>\n<td><strong>Treatment</strong></td>\n<td><strong>Complications</strong></td>\n</tr>\n<tr>\n<td>I</td>\n<td><strong>Uterine hypoplasia or uterine agenesis</strong></td>\n<td>Underdeveloped or non-developed paramesonephric duct</td>\n<td>\n<ul>\n<li>Infertility treatment -surrogacy&nbsp;</li>\n<li>Vaginoplasty for vaginal hypoplasia</li>\n</ul>\n</td>\n<td>Infertility\n<p>&nbsp;</p>\n</td>\n</tr>\n<tr>\n<td>II</td>\n<td><strong>Unicornuate uterus</strong></td>\n<td>Non-developed paramesonephric duct</td>\n<td>Excision of&nbsp;rudimentary horn, if any &nbsp;</td>\n<td>\n<ul>\n<li>Uterine rupture</li>\n<li>Abortions</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>III</td>\n<td><strong>Uterus didelphys</strong></td>\n<td>Unfused paramesonephric duct</td>\n<td>\n<p>Metroplasty- Resection of membrane and fundal recombination. This can be:</p>\n<ul>\n<li>Hysteroscopic</li>\n<li>Open e.g., Strassman metroplasty</li>\n</ul>\n</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>IV</td>\n<td><strong>Bicornuate uterus&nbsp;</strong></td>\n<td>Lower part is fused whereas upper part is unfused</td>\n<td>Metroplasty in selected cases&nbsp;</td>\n<td>\n<ul>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>V</td>\n<td><strong>Septate uterus&nbsp;</strong></td>\n<td>Septa of fused part persists</td>\n<td>Hysteroscopic septal resection&nbsp;</td>\n<td>\n<ul>\n<li>Infertility</li>\n<li>Risk of miscarriage,</li>\n<li>Malpresentation&nbsp;</li>\n<li>Preterm delivery</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>VI</td>\n<td><strong>Arcuate uterus</strong></td>\n<td>A small indentation at upper part</td>\n<td>&nbsp;</td>\n<td>&nbsp;</td>\n</tr>\n<tr>\n<td>VII</td>\n<td><strong>Diethylstillbesterone (DES), drug related</strong></td>\n<td>T-shaped uterus, shortened and narrow fallopian tubes, cervical collars (Cockscomb cervix)</td>\n<td>&nbsp;</td>\n<td>\n<ul>\n<li>Ectopic pregnancy</li>\n<li>Cervical incompetence</li>\n<li>Clear cell adenocarcinoma of cervix and vagina</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>A common complication is an abortion in the second trimester.</p>\n<p>Arcuate uterus: Some studies report no increase in adverse outcomes, whereas some studies have shown excessive second trimester loss, preterm labor and malpresentations.</p>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/b5daabaa46584f8ca9566b45a6d7c54dx1280x4923.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0153",
      "difficulty": "medium"
    },
    {
      "text": "A 20-year-old nulligravida presented with right flank pain. MRI evaluation revealed a solid, enhancing  5×13×7 cm right ovarian mass. Salpingo-oophorectomy was successfully done and microscopic examination of the tumor cells showed a close resemblance to primordial germ cells. It was also noticed that the tumor appeared histologically identical to a testicular seminoma. Which of the following is not secreted by this tumor?",
      "choices": [
        {
          "id": 1,
          "text": "Sex hormones"
        },
        {
          "id": 2,
          "text": "Lactate dehydrogenase"
        },
        {
          "id": 3,
          "text": "Placental alkaline phosphatase"
        },
        {
          "id": 4,
          "text": "Beta human chorionic gonadotropin"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>An ovarian tumor in a <strong>young woman</strong> which consists of primordial germ cells and is histologically similar to seminoma&nbsp;suggests a diagnosis of an <strong>ovarian</strong>&nbsp;<strong>dysgerminoma. </strong>It <strong>does not</strong> secrete <strong>sex hormones</strong>.</p>\n<p>Dysgerminoma usually arises in young women or in children, with an average incidence at the age of 20. It is the most common malignant germ cell tumour diagnosed during pregnancy.</p>\n<p>The tumor is neutral and does not secrete either male or female sex hormones. It <strong>secretes</strong> placental alkaline phosphatase (<strong>ALP</strong>), lactate dehydrogenase (<strong>LDH</strong>) and <strong>&beta;-hCG</strong>.&nbsp;Serum<strong> LDH</strong> and the isoenzymes LDH-1 and LDH-2 may be used in <strong>monitoring individuals or disease recurrence</strong>.</p>\n<p>Dysgerminomas are primitive neoplasms that do not have the potential for further differentiation. They are the only germ cell malignancy with a<strong> significant rate of bilateral ovarian involvement (15-20%).</strong></p>\n<p>Microscopically, there is a monotonous proliferation of large, rounded, polyhedral clear cells that are rich in cytoplasmic glycogen and contain uniform central nuclei with one or a few prominent nucleoli. The tumor cells are <strong>histologically identical</strong> to the <strong>seminoma</strong> of the testis. The counterpart of seminoma in females is dysgerminoma.&nbsp;</p>\n<p>Treatment involves <strong>fertility-sparing surgery</strong> with <strong>unilateral salpingo-oophorectomy</strong>. It is highly radiosensitive and has a good prognosis.</p>\n<p>The image below shows the histopathology of a dygerminoma, characterized by uniform cells resembling primordial germ cells separated by fibrous septa with lymphocytes.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0181b6c0f17c44279adc176ec6f8b13bx1280x853.JPEG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Markers of Ovarian Neoplasm</h3><table>\n<tbody>\n<tr>\n<td><strong>Ovarian tumor</strong></td>\n<td><strong>Tumor marker</strong></td>\n<td><strong>Pathognomonic finding</strong></td>\n</tr>\n<tr>\n<td>\n<p>Epithelial ovarian tumors</p>\n</td>\n<td>CA-125,&nbsp; CA-19-9, CEA</td>\n<td>Psammoma bodies (Serous epithelial tumor)</td>\n</tr>\n<tr>\n<td>Endodermal sinus tumor</td>\n<td>AFP</td>\n<td>Schiller-Duval bodies</td>\n</tr>\n<tr>\n<td>Dysgerminoma</td>\n<td>LDH, PLAP</td>\n<td>Lymphocytic infiltration</td>\n</tr>\n<tr>\n<td>Embryonal carcinoma</td>\n<td>AFP, HCG</td>\n<td>-</td>\n</tr>\n<tr>\n<td>Mature teratoma</td>\n<td>AFP</td>\n<td>Rokitansky protruberance</td>\n</tr>\n<tr>\n<td>Granulosa cell tumor</td>\n<td>Inhibin</td>\n<td>Call&ndash;Exner bodies</td>\n</tr>\n<tr>\n<td>Hilus cell tumor</td>\n<td>-</td>\n<td>Reinke's crystal</td>\n</tr>\n<tr>\n<td>Brenner tumor</td>\n<td>-</td>\n<td>Walthard cell nest</td>\n</tr>\n<tr>\n<td>Krukenberg tumor</td>\n<td>-</td>\n<td>Signet-ring cell</td>\n</tr>\n<tr>\n<td>Clear cell tumor</td>\n<td>-</td>\n<td>Hobnail cell</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>Dysgerminoma&nbsp;(Mnemonic: DPL= Delhi Premier League)</p>\n<ul>\n<li>D: Dysgerminoma</li>\n<li>P: PLAP (placental alkaline phosphatase)</li>\n<li>L: LDH (lactate dehydrogenase)</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF0165",
      "difficulty": "medium"
    },
    {
      "text": "A woman with endometrial carcinoma is undergoing radiotherapy. Which of the following is true?",
      "choices": [
        {
          "id": 1,
          "text": "Intensity is inversely proportional to squared distance"
        },
        {
          "id": 2,
          "text": "Small blood vessels are most radioresistant"
        },
        {
          "id": 3,
          "text": "Rapidly proliferating cells are most radioresistant"
        },
        {
          "id": 4,
          "text": "Small bowel is most radioresistant"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>intensity</strong> of radiation is <strong>inversely proportional </strong>to<strong>&nbsp;the squared distance. </strong>This is known as the <strong>inverse square law</strong>&nbsp;in radiotherapy.</p>\n<p><strong>Chemoradiation</strong> is the mainstay of treatment of <strong>stage III and IV</strong> endometrial cancers. They are treated with brachytherapy followed by external radiation.<span class=\"Apple-converted-space\">&nbsp;</span><strong><span class=\"Apple-converted-space\">Brachytherapy</span></strong><span class=\"Apple-converted-space\">&nbsp;</span>is a form of radiation therapy in which the <strong>radiation source </strong>is placed<strong> close to </strong>the <strong>tumor</strong>.<span class=\"Apple-converted-space\">&nbsp;</span></p>\n<p><span class=\"Apple-converted-space\">Other options:&nbsp;</span></p>\n<p>Option B: <strong>Larger blood vessels</strong> are more <strong>radioresistant</strong> than microvasculature.</p>\n<p>Option C: <strong>Permanent non-dividing cells</strong> are more <strong>radioresistant</strong> than rapidly proliferating cells.</p>\n<p>Option D: <strong>Small intestinal epithelial cells</strong> (intestinal crypts), which divide rapidly with no differentiation are the <strong>most radiosensitive</strong>.</p><hr><h3>Related Pearl: Ca.Endometrium staging (Revised FIGO)</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/63d7bd1024964af5a59c406cbaa3fc47x1280x3298.JPEG\" alt=\"Pearl Image\"><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4a582a55999043d8a33c2034dd59de86x1280x882.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: Management of endometrial cancer</h3><p>Surgery is done for staging of the cancer. The surgery done for this purpose is abdominal hysterectomy, bilateral salpingo-oophorectomy, omentectomy, and pelvic as well as para-aortic lymph node sampling.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Stage</strong></td>\n<td><strong>Treatment</strong></td>\n</tr>\n<tr>\n<td><strong>IA noninvasive&nbsp;</strong></td>\n<td>\n<ul>\n<li>Surgery alone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IA</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IB</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op pelvic radiotherapy 4000-5000 cGy</li>\n<li>Post-op vaginal vault radiotherapy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>II</strong></td>\n<td>\n<ul>\n<li>Surgery</li>\n<li>Post-op brachytherapy</li>\n<li>Post-op external beam radiotherapy</li>\n<li>Wertheim's hysterectomy</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>III</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Chemotherapy with Doxorubicin+Cisplatin+Paclitaxel</li>\n<li>Medroxyprogesterone&nbsp;adjuvant</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>IV</strong></td>\n<td>\n<ul>\n<li>Inoperable/ Cytoreduction</li>\n<li>Palliative radiotherapy/chemo/ progesterone therapy</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>*This pearl is in line with the FIGO 2010 guidelines. It will be updated according to the FIGO 2023 guidelines after an official treatment guideline is released.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3068",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old woman with an obstetric code of P3L3 came with complaints of heaviness in her pelvic region. The uterine prolapse was similar to the illustration given below. What is the degree of prolapse?",
      "choices": [
        {
          "id": 1,
          "text": "First degree"
        },
        {
          "id": 2,
          "text": "Second degree"
        },
        {
          "id": 3,
          "text": "Third degree"
        },
        {
          "id": 4,
          "text": "Procidentia"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The given condition is a <strong>second-degree uterine&nbsp;prolapse</strong>, where the cervix descends to the level of the vulva as seen in the image above.&nbsp;</p>\n<p>Pelvic organ prolapse is a condition where the <strong>pelvic organs</strong> <strong>herniate</strong> into the <strong>vagina</strong> due to <strong>weakness of supports</strong>. It is classified based on compartment of descent.&nbsp;</p>\n<p>It has <strong>multifactorial</strong> <strong>etiology</strong>. It is thought that combinations of anatomical, physiological, genetic, lifestyle, and reproductive factors are responsible for pelvic floor dysfunction. However, pregnancy, vaginal delivery, prior pelvic surgeries, or conditions associated with sustained episodes of increased intraabdominal pressure increase the risk of developing pelvic organ prolapse.&nbsp;</p>\n<p>Patients may be <strong>asymptomatic</strong>. Those who have <strong>symptoms</strong> may present with a feeling of a <strong>bulge</strong> <strong>protruding</strong> through the vaginal opening. It may cause <strong>bladder outlet obstruction</strong>, affect <strong>sexual activity</strong>, <strong>body</strong> <strong>image</strong>, and <strong>quality</strong> of <strong>life</strong>.&nbsp;</p>\n<p>The following image depicts the degrees of prolapse:&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a299ae481fa14be7a22a2f89a5746197x1064x2649.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/18a7986e5be243c4ad4ffb5c48fb4f7c.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3430",
      "difficulty": "medium"
    },
    {
      "text": "A 30-year-old woman presents to you with complaints of a constant leakage of urine and dysuria even after undergoing fistula repair surgery for vesicovaginal fistula. You decide to attempt a second fistula repair surgery. In order to perform the second surgery, you would counsel the patient to wait for at least",
      "choices": [
        {
          "id": 1,
          "text": "3 months"
        },
        {
          "id": 2,
          "text": "3 weeks"
        },
        {
          "id": 3,
          "text": "6 weeks"
        },
        {
          "id": 4,
          "text": "6 months"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In order to perform the second surgery, you should counsel the patient to wait for at least<strong>&nbsp;3 months.</strong></p>\n<p>The given scenario is suggestive of <strong>failed surgery</strong>.&nbsp;If the fistula repair fails, one should wait for <strong>at least 3 months</strong> before attempting a<strong> second repair.</strong></p>\n<p>Patients usually present with constant dribbling of urine (<strong>true incontinence</strong>). The&nbsp;<strong>constant leakage of urine may lead to excoriation</strong>&nbsp;of genital regions. The fistula&nbsp;located at the vaginal vault post-hysterectomy is the most difficult to treat.</p>\n<p><strong>Most vesicovaginal fistulae are repaired per vaginally.&nbsp;</strong>The various surgeries done for the repair of VVF (vesicovaginal fistula) are as follows:</p>\n<ul>\n<li>Latzko procedure</li>\n<li>Chasser Moir technique</li>\n<li>Ureteric implantation</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3678",
      "difficulty": "medium"
    },
    {
      "text": "A 38-year-old woman presents with dysmenorrhoea, menorrhagia, and infertility. After ruling out other possible causes, the gynecologist suspects endometriosis. Which of the following investigations will be most helpful in the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Hysteroscopy and endometrial biopsy"
        },
        {
          "id": 2,
          "text": "Transvaginal ultrasound"
        },
        {
          "id": 3,
          "text": "Laparoscopy"
        },
        {
          "id": 4,
          "text": "Hysterosalpingography"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical scenario, the investigation that will be most helpful in the diagnosis is <span data-preserver-spaces=\"true\"><strong>laparoscopy.</strong></span></p>\n<p><span data-preserver-spaces=\"true\">Endometriosis is the presence of endometrial tissue outside the uterus. The patient usually presents with symptoms of abdominal pain, <strong>dyspareunia</strong>, <strong>dysmenorrhea</strong>, and <strong>infertility</strong>. The presence of <strong>puckered spots</strong> in the posterior fornix is pathognomonic of endometriosis. It is an </span>estrogen-dependent<span data-preserver-spaces=\"true\"> disease of the </span><strong><span data-preserver-spaces=\"true\">childbearing age</span></strong><span data-preserver-spaces=\"true\"> group. The most common site of occurrence is the <strong>ovary,</strong> followed by the <strong>pouch of Douglas</strong>.</span></p>\n<p><span data-preserver-spaces=\"true\">The <strong>gold standard</strong> for the diagnosis of endometriosis is visual inspection by <strong>laparoscopy,</strong> preferably with histological confirmation. </span>Typically, there are small black dots, the so-called <strong>powder burns</strong>/<strong>tattooing</strong> seen on the uterosacral ligaments and pouch of Douglas. </p>\n<p><strong>Role of laparoscopy in endometriosis:</strong></p>\n<ul>\n<li>To detect and diagnose pelvic endometriosis.</li>\n<li>Locate the site of endometriosis and staging.</li>\n<li>To take biopsy</li>\n<li>To surgically treat endometriosis by ablation, removal.</li>\n</ul>\n<p>Other investigations:</p>\n<ul>\n<li>CA-125 levels are raised in endometriosis.</li>\n<li>Monocyte chemotactic protein (MCP-1) levels are raised in the peritoneal fluid of women with endometriosis.</li>\n<li>Transvaginal ultrasound reveals an echo-free cyst, low level echoes or clumps of high-density level echoes representing clots.</li>\n</ul>\n<p>The image below shows <strong>powder burns</strong>/<strong>tattooing</strong> appearance of endometriosis on diagnostic laparoscopy.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/3acf25b2ab86420ca72d1ba69399230cx720x547.PNG\" alt=\"Explanation Image\"><hr><h3>Related Pearl: Endometriosis</h3><p><strong>Sites of Endometriosis</strong>:</p>\n<ul>\n<li>Pelvic endometriosis: Pelvic peritoneum, the pouch of Douglas, uterosacral ligament.</li>\n<li>Rectovaginal endometriosis.</li>\n<li>Ovarian endometriosis.</li>\n<li>Chocolate cyst of the ovary.</li>\n<li>Other sites&mdash;appendix, pelvic lymph nodes.</li>\n<li>Metastatic&mdash; lungs, umbilicus, scar endometriosis.</li>\n</ul>\n<div class=\"page\" title=\"Page 258\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>One pathology review revealed that endometriosis has been identified on all organs except the spleen.</p>\n<p><strong>Examination findings in endometriosis</strong>:</p>\n<ul>\n<li>Abdomen: Cystic swelling, fixed and tender.</li>\n<li>Pelvis: Cystic tender mass.</li>\n<li>Vaginal examination: Fixed, tender, retroverted uterus. Tenderness in the lateral fornices (indicative of endometriosis even if no mass).<br />\n<ul>\n<li>Speculum inspection of the Posterior fornix: Bluish/blackish&nbsp;<strong>puckered spots</strong>&nbsp;on speculum, tender to touch.&nbsp;The presence of puckered spots is&nbsp;<strong>pathognomonic</strong>&nbsp;of endometriosis.</li>\n<li>Posterior Fornix Palpation: Uterosacral ligaments &amp; pouch of Douglas feel thickened and shotty with multiple small palpable nodules. This is called the&nbsp;<strong>cobblestone feel of uterosacral ligaments.</strong></li>\n</ul>\n</li>\n</ul>\n</div>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4715",
      "difficulty": "medium"
    },
    {
      "text": "Identify the instrument.",
      "choices": [
        {
          "id": 1,
          "text": "Sims speculum"
        },
        {
          "id": 2,
          "text": "Graves vaginal speculum"
        },
        {
          "id": 3,
          "text": "Cusco vaginal speculum"
        },
        {
          "id": 4,
          "text": "Auvard speculum"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The instrument shown in the image is <strong>Auvard speculum. </strong>It&nbsp;<strong>retracts</strong> the <strong>posterior vaginal wall</strong> during vaginal hysterectomy and is <strong>self retractory</strong> due to the circular structure on its handle which is heavy.</p>\n<p>The image given below shows Sim's speculum.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/6518af8355404115a4c38afbe9b47f5cx592x445.JPEG\" alt=\"Explanation Image\"><p>The image given below shows Cusco's self retaining bivalved speculum.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/83ad80af7979439e9f600d2bf3c03fdex1280x960.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/ce34173603f046da9eea818def91d2fd.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0201",
      "difficulty": "medium"
    },
    {
      "text": "A 48-year-old female patient presented with excessive, painless bleeding per vaginum for the past 8 days. This episode was preceded by two months of amenorrhea. The ultrasound revealed thickened endometrium, with thin slender polypi projecting into the uterine cavity, and associated myometrial hyperplasia. Which of the following statements is false regarding the condition?",
      "choices": [
        {
          "id": 1,
          "text": "Endometrial sampling is mandatory in evaluating the disease"
        },
        {
          "id": 2,
          "text": "The ovaries associated with this condition may have a cyst"
        },
        {
          "id": 3,
          "text": "Endometrial histology shows the presence of cork screw glands"
        },
        {
          "id": 4,
          "text": "This type of AUB is not related to parity"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of <strong>metropathia haemorrhagica,&nbsp;</strong>and the corkscrew glands are not seen in this condition.</p>\n<p>The endometrium shows characteristic <strong>cystic glandular hyperplasia</strong>, which appears as a <strong>swiss cheese pattern</strong>. The second feature is the absence of secretory endometrium<strong> i.e absence of corkscrew glands </strong>(as the bleeding is anovulatory, there is no progesterone and hence no secretory changes in the endometrium).</p>\n<p><strong>Metropathia haemorrhagica, is&nbsp;</strong>a specialized form of anovulatory abnormal uterine bleeding, is seen in women aged&nbsp;<strong>40 to 45 years</strong>.</p>\n<p>Typical symptoms are continuous painless vaginal bleeding at the onset of menses&nbsp;or preceded by a 6-8 week period of amenorrhoea. Occasionally the woman gives a history of menorrhagia prior to this.</p>\n<p>The uterus is <strong>slightly bulky</strong>,&nbsp;<strong>uniformly enlarged and the uterine wall shows a mild degree of myohyperplasia, measuring up to 2.5 cm</strong>. The endometrium is thick, polypoidal, and thin slender polyps project into the uterine cavity. <strong>Corpus luteum is absent</strong> and <strong>one or both ovaries may contain a cyst, not larger than 5 cm</strong>.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3313",
      "difficulty": "hard"
    },
    {
      "text": "What is the most common type of vaginal cancer likely to be seen in a woman with a history of intrauterine di-ethyl stilbesterol exposure?",
      "choices": [
        {
          "id": 1,
          "text": "Squamous cell carcinoma"
        },
        {
          "id": 2,
          "text": "Melanoma"
        },
        {
          "id": 3,
          "text": "Clear cell adenocarcinoma"
        },
        {
          "id": 4,
          "text": "Fibrosarcoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Clear cell adenocarcinoma of the vagina</strong> is commonly seen in adoloscent girls with a history of <strong>intrauterine&nbsp;DES exposure</strong>.&nbsp;</p>\n<p>It involves the upper third of the anterior vaginal wall.&nbsp;<strong>Radical hysterectomy, vaginectomy </strong>with <strong>pelvic lymphadenectomy</strong> is the treatment of choice.&nbsp;</p>\n<p>The most common lesion due to DES exposure is vaginal adenosis&nbsp;and not clear cell adenocarcinoma. It is a benign condition.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB5628",
      "difficulty": "medium"
    },
    {
      "text": "A 35-year-old female patient had complaints of post-coital bleeding with leucorrhoea. An initial visual inspection with acetic acid showed an abnormal finding, which, when followed by a colposcopic guided biopsy of the cervix,  had the malignant cells occupying the lower 50% to 75% of the epithelial thickness. She wishes for conservative treatment, as she has not completed her family. Which of the following might be offered considering the future pregnancy?",
      "choices": [
        {
          "id": 1,
          "text": "Conization"
        },
        {
          "id": 2,
          "text": "Needle excision of the transformation zone"
        },
        {
          "id": 3,
          "text": "Loop electrosurgical excision procedure"
        },
        {
          "id": 4,
          "text": "Laser ablation"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p>The given clinical scenario and the histologic finding are suggestive of high-grade squamous intraepithelial lesion (HSIL/CIN II) of the cervix. An ideal procedure to be performed in this patient, anticipating the future pregnancy would be <strong>laser ablation.</strong></p>\n<p>This is because <strong>ablative techniques</strong> do<strong> not result in future pregnancy complications.</strong></p>\n<p>Techniques involving the excision of abnormal tissue such as</p>\n<ul>\n<li>Large Loop Excision of the Transformation Zone (LLETZ)</li>\n<li>Loop Electrosurgical Excision Procedure (LEEP)</li>\n<li>Needle Excision of the Transformation Zone (NETZ)</li>\n<li>Cold knife conization</li>\n<li>Laser conization</li>\n</ul>\n<p>result in the stenosis of the cervix, abortion, and premature labour. Hence avoid in female patients who desire for childbirth in the near future</p><hr><h3>Related Pearl: Management of CIN</h3><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/1f5d51f1183f4d35857dd881e7f7f708x1280x1886.JPEG\" alt=\"Pearl Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3308",
      "difficulty": "hard"
    },
    {
      "text": "A woman with irregular periods was evaluated for infertility, and underwent an endometrial biopsy. The histology image is given below. Which phase is seen here?",
      "choices": [
        {
          "id": 1,
          "text": "Secretory phase"
        },
        {
          "id": 2,
          "text": "Proliferative phase"
        },
        {
          "id": 3,
          "text": "Menstrual phase"
        },
        {
          "id": 4,
          "text": "Ovulation phase"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The image depicts&nbsp;the<strong> proliferative phase</strong> of the endometrium.&nbsp;</p>\n<p>During menstruation, the <strong>endometrium</strong> goes through three phases, namely; <strong>proliferative, secretory,</strong> and <strong>menstrual phases</strong>. Their histological features are given below:</p>\n<p><strong>Proliferative phase</strong></p>\n<ul>\n<li>The glands of the functional layer are simple tubules with regular epithelium.</li>\n<li>Arteries become more coiled and spiralled.</li>\n<li>The endometrium is thick, the stoma is compact and short straight glands are present.</li>\n</ul>\n<p>The image below shows proliferative endometrium</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/58ac5c263e1d4f198bbd254a47835df8x400x600.JPEG\" alt=\"Explanation Image\"><p><strong>Secretory phase&nbsp;</strong></p>\n<div class=\"page\" title=\"Page 43\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>The secretory phase of the endometrium begins on the 15th day and persists until the onset of menstruation.</li>\n<li>Subnuclear vacuolation (presumptive evidence of progesterone activity)</li>\n<li>Corkscrew-shaped glands</li>\n</ul>\n</div>\n</div>\n</div>\n<p>The image below shows secretory endometrium</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/61ff20584c2e42ada4af6f4653d56b22x1279x963.JPEG\" alt=\"Explanation Image\"><p><strong>Menstrual phase:&nbsp;</strong>Glands shrink with prominent vessels and haemorrhagic spots.&nbsp;</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/420f42c729784a1696b9a05d70fd68bf.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0622",
      "difficulty": "medium"
    },
    {
      "text": "A menopausal woman presents with complaints of hot flushes. Which of the following neurotransmitters are responsible for these symptoms?",
      "choices": [
        {
          "id": 1,
          "text": "Serotonin and epinephrine"
        },
        {
          "id": 2,
          "text": "Serotonin and norepinephrine"
        },
        {
          "id": 3,
          "text": "Adrenaline and epinephrine"
        },
        {
          "id": 4,
          "text": "Noradrenaline and epinephrine"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Norepinephrine</strong> and <strong>serotonin</strong> are responsible for hot flushes in menopausal women.</p>\n<p>A fall in the level of estrogen causes a reduction in hypothalamic endorphins. This causes a release of more norepinephrine and serotonin, which <strong>lower</strong> the <strong>set point</strong> in the&nbsp;<strong>thermoregulatory nucleus</strong>. As a result, the heat-loss mechanism is triggered by even subtle changes in core body temperature.</p>\n<p>Risk factors for hot flushes:</p>\n<ul>\n<li>Low estradiol levels</li>\n<li>High BMI</li>\n<li>Sedentary lifestyle</li>\n<li>Surgical menopause has increased risk</li>\n<li>Low socioeconomic status</li>\n<li>History of premenstrual dysphoric disorder (PMDD)</li>\n<li>Depression.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0902",
      "difficulty": "medium"
    },
    {
      "text": "The secretion of FSH in men is inhibited by the negative feedback effect of _______.",
      "choices": [
        {
          "id": 1,
          "text": "Inhibin secreted by Sertoli cells"
        },
        {
          "id": 2,
          "text": "Inhibin secreted by Leydig cells"
        },
        {
          "id": 3,
          "text": "Testosterone secreted by Sertoli cells"
        },
        {
          "id": 4,
          "text": "Androstenedione secreted by Leydig cells"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The secretion of <strong>FSH</strong> in men is <strong>inhibited</strong> by the negative feedback effect of<strong> inhibin</strong> secreted by <strong>Sertoli cells</strong>.</p>\n<p>GnRH stimulates the anterior pituitary gland to secrete FSH (follicle-stimulating hormone) and LH (luteinizing hormone). FSH acts on Sertoli cells while<strong> LH triggers testosterone</strong> secretion by the <strong>Leydig&nbsp;cells</strong>.&nbsp;Sertoli cells&nbsp;secrete <strong>inhibin B</strong> which in turn inhibits FSH but <strong>stimulate LH</strong> secretion.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/0d9a0ab366124669b2425ed37294fdc6x265x450.PNG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB1360",
      "difficulty": "medium"
    },
    {
      "text": "What will be the level of the anti-Mullerian hormone in low ovarian reserve?",
      "choices": [
        {
          "id": 1,
          "text": "<1"
        },
        {
          "id": 2,
          "text": "1-4"
        },
        {
          "id": 3,
          "text": ">7"
        },
        {
          "id": 4,
          "text": ">10"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In<strong> low ovarian reserve,</strong> the level of<strong> anti-Mullerian hormone</strong> (AMH)<strong> </strong>will be<strong> &lt;1 ng/ml. </strong></p>\n<p><strong>AMH</strong> is a glycoprotein secreted by the granulosa cells of the primordial follicle of the ovary. It helps in oocyte maturation and mono-follicular development. AMH is also used in assessing ovarian reserve.</p>\n<table>\n<tbody>\n<tr>\n<td><strong>AMH levels in ng/ml</strong></td>\n<td><strong>Interpretation</strong></td>\n</tr>\n<tr>\n<td>2–6.8</td>\n<td>Normal</td>\n</tr>\n<tr>\n<td>&lt;1</td>\n<td>Poor ovarian reserve</td>\n</tr>\n<tr>\n<td>&gt;10</td>\n<td>\n<p>PCOD</p>\n<p>Hyperstimulation syndrome</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>In<strong> women</strong>, AMH is always absent during embryogenesis and is <strong>secreted by</strong> the <strong>granulosa cells</strong> after puberty. It helps in follicular development and oocyte maturation. <strong>Estimation of</strong> serum AMH is used in the study of<strong> ovarian reserve</strong> in female infertility and secondary amenorrhoea.</p>\n<p>In <strong>men</strong>, AMH starts to be <strong>secreted by</strong> the<strong> Sertoli cells</strong> in the testes by the 7th week of intrauterine life. It continues until puberty. It inhibits the development of the Müllerian system. The <strong>absence</strong> of AMH results in the development of <strong>hermaphroditism</strong>. </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7530",
      "difficulty": "medium"
    },
    {
      "text": "The following hysterosalpingogram indicates",
      "choices": [
        {
          "id": 1,
          "text": "Asherman syndrome"
        },
        {
          "id": 2,
          "text": "Bilateral hydrosalpinges"
        },
        {
          "id": 3,
          "text": "Submucous leiomyoma"
        },
        {
          "id": 4,
          "text": "Normal hysterosalpingogram"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given image is of a hysterosalpingogram showing the contrast dye filling an irregulary shaped edometrial cavity often described as \"moth-eaten\" appearance. Hence, it is <strong>Asherman syndrome</strong>.</p>\n<p>The presence of intrauterine adhesions is called Asherman syndrome. Destruction of the basal endometrium prevents endometrial thickening, thus no tissue is produced. <strong>Endometrial damage may follow vigorous curettage in association with PPH, miscarriage, or elective abortion. </strong></p>\n<p>If intrauterine adhesions are suspected:</p>\n<ul>\n<li><strong>Radiological evaluation</strong> of the uterine cavity is performed.</li>\n<li><strong>Hysterosalpingography (HSG)</strong> offers information regarding both uterine cavity and fallopian tube patency.</li>\n<li><strong>Saline infusion sonography</strong> can be performed alternative to HSG.</li>\n<li>Definitive diagnosis requires <strong>hysteroscopy</strong> as polyps, leiomyomas, air bubbles and blood clots may masquerade as adhesions.</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5321a787ac49418bae9910b19db29c96x800x308.JPEG\" alt=\"Explanation Image\"><p>The above image is a hysteroscopic image of intrauterine adhesions found with Asherman syndrome.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/4e30d1c9238b4aa785b8ac05612b4d83.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB8762",
      "difficulty": "easy"
    },
    {
      "text": "Metrorrhagia refers to _______",
      "choices": [
        {
          "id": 1,
          "text": "Regularly timed episodes of bleeding superimposed on normal cyclical bleeding"
        },
        {
          "id": 2,
          "text": "Irregularly timed episodes of bleeding superimposed on abnormal cyclical bleeding"
        },
        {
          "id": 3,
          "text": "Regularly timed episodes of bleeding superimposed on abnormal cyclical bleeding"
        },
        {
          "id": 4,
          "text": "Irregularly timed episodes of bleeding superimposed on normal cyclical bleeding"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Irregularly timed episodes</strong> of bleeding superimposed on <strong>normal cyclical</strong> bleeding are referred to as <strong>metrorrhagia</strong>.</p>\n<p>Menstrual cycle irregularities<span class=\"Apple-converted-space\"> are as follows:</span></p>\n<ul>\n<li><strong>Menometrorrhagia&nbsp;</strong>refers to excessive, prolonged bleeding that occurs irregularly and at frequent intervals.</li>\n<li><strong>Oligomenorrhea&nbsp;</strong>refers to infrequent, irregularly timed episodes of bleeding occurring at intervals of more than 35 days.</li>\n<li><strong>Amenorrhea&nbsp;</strong>indicates the absence of menstruation.<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li><strong>Polymenorrhea&nbsp;</strong>indicates frequent episodes of menstruation that occur at intervals of 21 days or lesser.<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li><strong>Menorrhagia </strong>refers to regularly timed episodes of bleeding that are excessive in amount (&gt;80 mL) and/or duration of flow (&gt;5 days).<span class=\"Apple-converted-space\">&nbsp;</span></li>\n<li><strong>Intermenstrual&nbsp;</strong>bleeding refers to bleeding (usually not excessive) that occurs between otherwise normal menstrual cycles.</li>\n<li><strong>Precocious&nbsp;</strong>menstruation is the occurrence of menstruation before the age of 10 years.</li>\n<li><strong>Postcoital bleeding</strong> is vaginal bleeding after sexual intercourse.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB3611",
      "difficulty": "medium"
    },
    {
      "text": "Halban's disease is ______",
      "choices": [
        {
          "id": 1,
          "text": "Irregular shedding  due to persistent corpus luteum"
        },
        {
          "id": 2,
          "text": "Menstruation is irregular"
        },
        {
          "id": 3,
          "text": "Irregular ripening"
        },
        {
          "id": 4,
          "text": "Due to adenomatous polyp"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<div class=\"page\" title=\"Page 360\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Halbans disease is irregular shedding due to persistent corpus luteum.</li>\n<li>It is rare and usually self-limiting.&nbsp;</li>\n<li>Menstruation occurs on time and is prolonged but not heavy.</li>\n</ul>\n</div>\n</div>\n</div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC0095",
      "difficulty": "easy"
    },
    {
      "text": "An increase in which of the following is spasmodic pain during dysmenorrhoea attributed to?",
      "choices": [
        {
          "id": 1,
          "text": "PGE1"
        },
        {
          "id": 2,
          "text": "PGE2"
        },
        {
          "id": 3,
          "text": "PGD2"
        },
        {
          "id": 4,
          "text": "PGF2α"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Spasmodic pain</strong> is attributed to myometrial contractions occuring due to<strong> increased PGF2&alpha;.</strong>&nbsp;This is secreted under the effect of<strong> pr</strong><strong>ogesterone.</strong></p>\n<p>Progesterone is secreted after ovulation by the corpus luteum. Hence, in <strong>anovulatory</strong> <strong>cycles</strong>,&nbsp;menstruation is <strong>not accompanied by spasmodic pain.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC6972",
      "difficulty": "medium"
    },
    {
      "text": "A 33-year-old woman presents to the clinic with complaints of dull aching pain in the lower abdomen for the past 8 months. There is no clinical evidence of any pelvic pathology. She says the pain decreases on lying down and increases on walking, bending, and standing. You diagnose her with having chronic pelvic pain syndrome. Which of the following is false regarding this syndrome?",
      "choices": [
        {
          "id": 1,
          "text": "Conscious pain mapping is not useful in diagnosis"
        },
        {
          "id": 2,
          "text": "Venography is useful in diagnosis"
        },
        {
          "id": 3,
          "text": "Associated with polycystic ovarian disease"
        },
        {
          "id": 4,
          "text": "Treatment is with progesterone"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p class=\"p1\"><strong>Conscious pain mapping</strong> is a useful investigation in the diagnosis of <strong>chronic pelvic pain syndrome.</strong></p>\n<p class=\"p1\">Chronic pelvic pain (CPP) refers to <strong>acyclical</strong> pelvic pain of <strong>more than 6 months</strong> duration. </p>\n<p class=\"p1\"><strong>Chronic pelvic pain syndrome</strong> is a condition characterized by CPP <strong>not associated</strong> with any clinical evidence of pelvic pathology. It possibly occurs because of dilated pelvic veins. And, hence, <strong>shifting the location of pain</strong> with body movement is characteristic of this syndrome. It is associated with congestive dysmenorrhea, dyspareunia, postcoital ache, and <strong>polycystic ovary syndrome (PCOS).</strong> Doppler ultrasound and <strong>venography help in the diagnosis. </strong><strong>Conscious pain mapping </strong>at<strong> </strong>laparoscopy under local anesthesia is useful in deciding the cause and location of chronic pain. This improves diagnostic accuracy.</p>\n<p class=\"p1\"><strong>Treatment </strong>comprises progestogen therapy. Progestogens, by their anti-estrogenic effect, constrict the veins, reduce blood flow, and suppress ovulation. </p>\n<p class=\"p4\"> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2493",
      "difficulty": "medium"
    },
    {
      "text": "You are inserting Nova-T in a patient for spacing of births. This device contains______.",
      "choices": [
        {
          "id": 1,
          "text": "Copper and silver"
        },
        {
          "id": 2,
          "text": "Copper and aluminium"
        },
        {
          "id": 3,
          "text": "Only copper"
        },
        {
          "id": 4,
          "text": "Copper and selenium"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>Nova-T</strong> contains both&nbsp;<strong>copper </strong>and<strong> silver.&nbsp;</strong>The addition of the silver increases its effective lifespan.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/9f36d723733445339481cca90bf386fdx1280x1512.JPEG\" alt=\"Explanation Image\"><p>In copper-carrying devices,&nbsp;copper wire is wrapped around the vertical stem of a polypropylene frame. Some of them have copper wire wrapped around the arms too. Based on the surface area, they are of various types:</p>\n<ul>\n<li>Copper T 380 A</li>\n<li>Multiload copper 250</li>\n<li>Copper T 200</li>\n<li>Copper 7</li>\n<li>Copper T 220</li>\n<li>Nova-T</li>\n</ul>\n<p>They are <strong>effective</strong> for&nbsp;<strong>3&ndash;5 years</strong>. It is estimated that about <strong>50 mcg</strong> of<strong> copper</strong> is <strong>eluted daily</strong> in the uterus. <strong>Copper T 380A</strong>, known as Paraguard, has a lifespan of <strong>10 years</strong>. <strong>Nova T</strong> has a lifespan of <strong>5 years</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/25e1581e0a434440b4f7b96680fcb722x1280x5453.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB9322",
      "difficulty": "medium"
    },
    {
      "text": "An actress wants to undergo a permanent method of sterilization. However, she is concerned about the resulting scars on her abdomen. Which of the following methods of sterilization would best suit her case?",
      "choices": [
        {
          "id": 1,
          "text": "Irving"
        },
        {
          "id": 2,
          "text": "Madlener"
        },
        {
          "id": 3,
          "text": "Essure"
        },
        {
          "id": 4,
          "text": "Pomeroy"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p><strong>Essure </strong>would best suit the actress as it is done through the <strong>hysteroscopic method, </strong>thus, avoiding abdominal scar.</p>\n<p>The<strong> Essure</strong> <strong>permanent device</strong> is the latest method of <strong>h</strong><strong>ysteroscopic sterilization. </strong>It is a dynamically expanding micro-inserter consisting of a flexible inner coil made of stainless steel and a dynamic outer coil made of nickel-titanium alloy (nitinol). In the inner coil, there is a layer of polyethylene terephthalate fibers that <strong>occludes</strong> the <strong>fallopian tube by</strong> initiating a benign local <strong>fibrous tissue growth.</strong>&nbsp;This is an <strong>irreversible</strong> and <strong>permanent</strong> technique. Tubal blockage can be confirmed 3 months later by hysterosalpingography. Its <strong>advantages</strong> are that there is <strong>no abdominal scar</strong> and that it can be <strong>done</strong> under <strong>local anesthesia.</strong></p>\n<p>However, disadvantages include:</p>\n<ul>\n<li>Hysteroscopy is required to insert the Essure device</li>\n<li>Cost and expertise required</li>\n<li><strong>Permanent method</strong></li>\n<li>HSG to confirm blockage after 3 months</li>\n<li>Bilateral insertion is difficult due to spasms in 15% of cases</li>\n<li>Tuboplasty for reversal is not possible</li>\n<li>Perforation of the tube&nbsp;</li>\n<li>The failure rate is 3.5%</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5c36816bd10a4668a9fc86a29b35d909x800x359.JPEG\" alt=\"Explanation Image\"><p>Other options</p>\n<p>Option A: <strong>Irving procedure</strong>&nbsp;involves&nbsp;<strong>ligating</strong>&nbsp;and&nbsp;<strong>excising</strong>&nbsp;the&nbsp;<strong>mid-portion</strong>&nbsp;of the tube after which&nbsp;the&nbsp;<strong>proximal stump</strong>&nbsp;is buried into the&nbsp;<strong>myometrium</strong>&nbsp;and&nbsp;the&nbsp;<strong>distal stump</strong>&nbsp;is buried in the&nbsp;<strong>broad ligament.</strong>&nbsp;It is an irreversible technique and may require a laparotomy incision.</p>\n<p>The procedure described in the image below is the&nbsp;Irving procedure.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/ad5275f8ee084e039575558adaafaf56x1279x996.JPEG\" alt=\"Explanation Image\"><p>Option B:&nbsp; <span>In <strong>Madlener's procedure</strong> a loop of the <strong>tube</strong> is <strong>crushed</strong> and <strong>ligated</strong> with a non-absorbable suture.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/77ee044c1c90457488bf4c337d140b58x1279x973.JPEG\" alt=\"Explanation Image\"><p>Option D: In the <strong>Pomeroy procedure</strong>&nbsp;the fallopian tube is identified on each side, brought out through the incision, and the <strong>middle portion</strong>&nbsp;is formed into a&nbsp;<strong>loop</strong>&nbsp;which is&nbsp;<strong>tied</strong>&nbsp;at the base with catgut and&nbsp;<strong>excised</strong>&nbsp;as shown in the image below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/f2c8c67f9f7d4fb48660f298aa5d5833x1280x973.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3424",
      "difficulty": "easy"
    },
    {
      "text": "A woman presents with cyclical hematuria 8 months after an emergency cesarean section was done for non-progress of labor. There is no urinary incontinence. Which of the following is the most likely diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "Vesicovaginal fistula"
        },
        {
          "id": 2,
          "text": "Vesicouterine fistula"
        },
        {
          "id": 3,
          "text": "Ureterovaginal fistula"
        },
        {
          "id": 4,
          "text": "Urethrovaginal fistula"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><span>T<span>he given clinical features are suggestive of <strong>vesicouterine fistula</strong>. </span></span></p>\n<p><span>Vesicouterine&nbsp;fistula occurs during <strong>cesarean section </strong>or uterine rupture or placenta accreta.<strong>&nbsp;</strong>Patients complain of <strong>cyclical hematuria </strong>due to the trickling of&nbsp;menstrual blood into the bladder through this anomalous condition. But the urinary<strong> continence</strong> of the patient remains <strong>normal</strong>. This is also known as <strong>Youssef syndrome</strong>.&nbsp;</span></p>\n<p><span>Other causes of cyclical hematuria can be intrauterine contraceptive device (IUCD) perforation into the bladder or&nbsp;bladder endometriosis. True pathology can be confirmed by cystoscopy.</span></p>\n<p><span>Treatment:</span></p>\n<ul>\n<li><span>Prolonged bladder catheterization can close the fistula.&nbsp;</span></li>\n<li><span>Abdominal repair using omental or gracilis graft is done if the prolonged catheterization fails.</span></li>\n</ul>\n<p><span>Methylene blue swab test:</span></p>\n<p><span>In the <strong>methylene blue 3-swab test</strong>, a catheter is introduced into the bladder through the urethra. The vaginal cavity is packed with three sterile cotton swabs. One at the vault, one at the middle, and one just above the introitus. A diluted solution of methylene blue dye is injected into the bladder using a transurethral catheter. After 15 to 30 minutes, the swabs are removed serially and inspected for dye.</span></p>\n<p><span>Interpretation:</span></p>\n<ul>\n<li><span>The<strong>&nbsp;uppermost</strong>&nbsp;swab gets wet and not stained - the leak is from the ureter, seen in the&nbsp;<strong>u</strong><strong>reterovaginal</strong>&nbsp;fistula</span></li>\n<li><span>The<strong> middle</strong> swab gets stained - the leak is from the bladder, seen in&nbsp;<strong>v</strong><strong>esicovaginal</strong>&nbsp;fistula</span></li>\n<li><span>The<strong>&nbsp;lowermost</strong>&nbsp;swab gets stained- the leak is from the urethra,&nbsp;seen in the&nbsp;<strong>u</strong><strong>rethrovaginal</strong>&nbsp;fistula</span></li>\n</ul>\n<p><span>The given image shows the 3-swab test.</span></p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/4ee333581ff345c6ac424e721c666326x1279x966.JPEG\" alt=\"Explanation Image\"><p><span>Other options:</span></p>\n<p><span>Option A: In a <strong>vesicovaginal fistula</strong>, the main complaint will be <strong>constant dribbling</strong> of urine (<strong>true incontinence</strong>).&nbsp;It usually follows difficult childbirth. A positive methylene blue test confirms the diagnosis.&nbsp;</span></p>\n<p><span>Option C:&nbsp;<strong>Ureterovaginal fistulae</strong> result from direct injury to the ureter during gynecologic surgery (Eg: Wertheim's procedure for Ca cervix). <strong>Urine dribbles </strong>from both<strong> vagina and urethra</strong>&nbsp;post-surgery. The three-swab test&nbsp;will not stain with methylene blue, but with urine.</span></p>\n<p><span>Option D: In <strong>urethrovaginal fistulae</strong>, the patient is <strong>continent and dry</strong>, but may <strong>dribble urine during micturition</strong>. This usually follows surgery for a paravaginal cyst or urethral diverticulum, or after a penetrating injury from a fall or criminal abortion. The fistulous opening is visible on speculum examination.</span></p><hr><h3>Related Pearl: Difference between bladder fistula & ureteric fistula</h3><table>\n<tbody>\n<tr>\n<td>&nbsp;</td>\n<td><strong>Bladder fistula&nbsp;&nbsp;</strong></td>\n<td><strong>Ureteric fistula&nbsp;</strong></td>\n</tr>\n<tr>\n<td><strong>Etiology</strong></td>\n<td>\n<p>Obstetric causes:</p>\n<div class=\"page\" title=\"Page 232\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<ul>\n<li>Prolonged obstructed labor</li>\n<li>Instrumental deliveries</li>\n<li>Iatrogenic injury during caesarean section or sling operations</li>\n</ul>\n</div>\n</div>\n</div>\n</div>\n</td>\n<td>\n<p>Surgical injury during:</p>\n<ul>\n<li>Abdominal hysterectomy</li>\n<li>Vaginal hysterectomy</li>\n<li>Wertheim's hysterectomy</li>\n<li>Laparoscopic surgeries</li>\n<li>Caesarean section</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td><strong>Clinical features</strong></td>\n<td>\n<p>Dribbling of urine present from the vagina</p>\n<p>The patient is unable to micturate</p>\n</td>\n<td>\n<p>Dribbling of urine present from the vagina</p>\n<p>The patient is able to micturate</p>\n</td>\n</tr>\n<tr>\n<td><strong>Methylene blue 3-swab test</strong></td>\n<td>Middle swab stains with methylene blue &nbsp;</td>\n<td>Uppermost swab stains with urine, but not with methylene blue</td>\n</tr>\n<tr>\n<td><strong>Intravenous pyelography</strong></td>\n<td>Normal</td>\n<td>Hydronephrosis and hydroureter present on the affected side</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2667",
      "difficulty": "medium"
    },
    {
      "text": "A 55-year-old multiparous woman presents to you with complaints of genuine stress urinary incontinence(GSI). Investigation revealed loss of posterior urethrovesical angle and urethral hypermobility with normal intrinsic sphincter activity. Identify the type of GSI seen in this patient from the surgical procedure point of view?",
      "choices": [
        {
          "id": 1,
          "text": "Type 3 GSI"
        },
        {
          "id": 2,
          "text": "Type 1 GSI"
        },
        {
          "id": 3,
          "text": "Type 4 GSI"
        },
        {
          "id": 4,
          "text": "Type 2 GSI"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<p><strong>Type 2 GSI&nbsp;</strong>has been described in the above patient.</p>\n<p>Genuine stress incontinence (GSI) occurs when the bladder pressure exceeds urethral pressure during physical stress in the absence of detrusor contraction</p>\n<p class=\"p1\">Considering the surgical procedure that should be done, GSI is classified into three types:</p>\n<ul>\n<li class=\"p1\">Type I: GSI occurs due to loss of posterior urethrovesical angle alone.</li>\n<li class=\"p1\"><strong>Type II</strong>: Loss of posterior urethrovesical angle as well as urethral hypermobility.</li>\n<li class=\"p1\">Type III: It is due to intrinsic sphincter deficiency.</li>\n</ul>\n<p class=\"p1\">Grading of GSI:</p>\n<ul>\n<li class=\"p1\">Grade I: Incontinence with only severe stress, such as coughing, sneezing, and jogging.</li>\n<li class=\"p3\">Grade II: Incontinence with moderate stress, such as fast walk, going up and down the stairs.</li>\n<li class=\"p4\">Grade III: Incontinence with mild stress such as standing.</li>\n</ul>\n<p>Tests done for GSI(Genuine stress incontinence) are:</p>\n<ol>\n<li>Stress test</li>\n<li>Cotton swab stick test</li>\n<li>Marshall and Bonney test</li>\n<li>Urethroscopy</li>\n<li>Urodynamic evaluation- cystometry, urethrocystometry, uroflowmetry, etc</li>\n</ol>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7431",
      "difficulty": "medium"
    },
    {
      "text": "A 27-year-old female patient presents with irregular periods, hirsutism, and infertility. Her ultrasound scan revealed the finding shown in the image below. Which of the following options is not correct regarding the USG criteria for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "At least 10 follicles should be present for diagnosis"
        },
        {
          "id": 2,
          "text": "Each follicle should be 2 to 9 mm in size"
        },
        {
          "id": 3,
          "text": "Ovarian volume >10 ml"
        },
        {
          "id": 4,
          "text": "Ovarian changes are not applicable if the woman is on OCPs"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The given clinical scenario and the ultrasound shows multiple ovarian follicles arranged in a <strong>necklace pattern,</strong> which is a feature of <strong>polycystic ovarian disease (PCOD). </strong>At least<strong> 12 follicles</strong> each measuring 2 to 9 mm should be seen on an ultrasound.</p>\n<p><span> USG Criteria: </span></p>\n<ul>\n<li>Increased ovarian stroma </li>\n<li>≥12 follicles(Rotterdam criteria)/ <strong>≥20 follicles</strong>(New criteria) each measuring 2 to 9 mm arranged in a necklace pattern</li>\n<li>Ovarian volume ≥10 ml</li>\n<li>These ovarian changes are <strong>not</strong> applicable if the woman is on combined oral pills, as these pills alter the ovarian morphology.</li>\n<li>A single ovary meeting these criteria is enough to diagnose PCOD.</li>\n</ul>\n<p><strong>Rotterdam criteria</strong> is used to diagnose polycystic ovarian syndrome (<strong>PCOS</strong>). The presence of <strong>any two of the three</strong> components of this criteria establishes the diagnosis of PCOS.</p>\n<p><strong>Rotterdam criteria</strong> (ASRM/ESHRE- European Society of Human Reproduction and Embryology, 2003):</p>\n<ul>\n<li>Clinical/biochemical hyperandrogenism</li>\n<li>Oligo/anovulation</li>\n<li>Polycystic ovaries</li>\n</ul>\n<p><strong>Other criteria for diagnosing polycystic ovarian syndrome:</strong></p>\n<p>National Institute of Health (<strong>NIH, </strong>1990):</p>\n<ul>\n<li>Clinical/biochemical hyperandrogenism</li>\n<li>Oligo/anovulation</li>\n</ul>\n<p>Androgen excess and PCOS society (<strong>AE-PCOS</strong>):</p>\n<ul>\n<li>Clinical/biochemical hyperandrogenism</li>\n<li>Oligo/anovulation/polycystic ovaries</li>\n</ul><p>Necklace appearance of right ovary on USG in PCOD:</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a8d01147a99f4e51b7feb89e21dee32dx512x381.PNG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/765e3240a9634fa5b4bd41a512d88129.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD6911",
      "difficulty": "medium"
    },
    {
      "text": "A senior resident asks you to grade hirsutism using the modified Ferriman Gallwey scoring method in a 25-year-old female patient. After examining all the areas, you assign a score of 3 for each area. The total score in this patient is found to be _______",
      "choices": [
        {
          "id": 1,
          "text": "33"
        },
        {
          "id": 2,
          "text": "18"
        },
        {
          "id": 3,
          "text": "27"
        },
        {
          "id": 4,
          "text": "24"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The total Modified Ferriman Gallwey score in the above patient is found to be 27.</p>\n<p>Modified Ferriman Gallwey scoring system:</p>\n<ul>\n<li>It is used to quantify the degree of hirsutism</li>\n<li class=\"p1\">In this system, abnormal hair distribution is assessed in <strong>nine body areas&nbsp;</strong>(Therefore the total score in the above patient is 27)&nbsp;and a score of&nbsp;0 to 4 is given for each area. Increasing numeric scores correspond to greater hair density within a given area.&nbsp;</li>\n<li class=\"p1\">The following are the nine areas, which are used to assess hirsutism,\n<ul>\n<li class=\"p1\">Upper lip</li>\n<li class=\"p1\">Chin</li>\n<li class=\"p1\">Chest</li>\n<li class=\"p1\">Upper abdomen</li>\n<li class=\"p1\">Lower abdomen</li>\n<li class=\"p1\">Thighs</li>\n<li class=\"p1\">Back</li>\n<li class=\"p1\">Arms and</li>\n<li class=\"p1\">Buttocks</li>\n</ul>\n</li>\n<li><strong>The maximum score</strong>&nbsp;is&nbsp;<strong>36</strong>\n<ul>\n<li>A score of 8 to 15 indicates mild hirsutism</li>\n<li>A score greater than 15 indicates moderate or severe hirsutism.</li>\n</ul>\n</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7438",
      "difficulty": "medium"
    },
    {
      "text": "A pap smear was done on a 39-year-old woman as a part of a routine health checkup. The cytology picture is shown below. The cell marked A in the smear is _______.",
      "choices": [
        {
          "id": 1,
          "text": "Progesterone dominant cell"
        },
        {
          "id": 2,
          "text": "Estrogen dominant cell"
        },
        {
          "id": 3,
          "text": "Basal cell"
        },
        {
          "id": 4,
          "text": "Human papilloma virus-infected cell"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The cell marked A in the smear is a <strong>superficial cell</strong> which is an <strong>estrogen-dominant</strong> cell. These are <strong>acidophilic</strong> (pink) cells with a <strong>pyknotic nucleus</strong> seen predominantly in the first half of the menstrual cycle.</p>\n<ul>\n<li><strong>Intermediate cells</strong>: <strong>Progesterone dominant</strong> cells which are<strong> basophilic</strong> (blue or green) with distinct margins and nuclei bigger than that of superficial cells. These are seen in the 2nd half of the menstrual cycle and pregnancy.</li>\n<li><strong>Basal and parabasal</strong> <strong>cells </strong>are seen when <strong>no hormone </strong>predominates. These are basophilic cells with no distinct outlines and a much larger nucleus. Seen in <strong>menopause </strong>and the postpartum period.</li>\n<li><strong>Human papilloma infected cells</strong>: Shows koilocytes. These cells have <strong>hyperchromatic enlarged nuclei</strong> and <strong>perinuclear halo</strong>.</li>\n</ul>\n<p>The cytology image of a normal Pap smear is shown below.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/54a577601c30464b82e816c2acaf8a60x795x600.JPEG\" alt=\"Explanation Image\"><p>The koilocytes(right side) compared to normal Pap smear(left side).</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/905551e60fef4be2b8e791d236f3ad73x529x337.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/7735a0450b92414c900adc1866fc4e61.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD2828",
      "difficulty": "easy"
    },
    {
      "text": "A middle-aged woman presented to the emergency department with signs of shock. Upon further investigations, a diagnosis of a ruptured tubo-ovarian mass was made. At what stage of pelvic inflammatory disease is she in?",
      "choices": [
        {
          "id": 1,
          "text": "Stage 4"
        },
        {
          "id": 2,
          "text": "Stage 3"
        },
        {
          "id": 3,
          "text": "Stage 2"
        },
        {
          "id": 4,
          "text": "Stage 5"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The <strong>ruptured tubo-ovarian mass</strong> belongs to <strong>stage IV</strong> of pelvic inflammatory diseases. It usually presents with a sudden worsening of the patient's condition.</p>\n<p>Tubo ovarian abscess is a complication of acute pelvic inflammatory disease (PID). It can be <strong>unilateral or bilateral</strong> and is characterized by dull or sharp abdominal pain. It is associated with other features like <strong>fever </strong>and<strong> </strong>an<strong> adnexal mass</strong>. On auscultation, a <strong>frictional rub</strong> can be heard throughout all quadrants of the abdomen which can be suggestive of a ruptured ovarian abscess. </p>\n<p>Treatment involves the administration of parenteral antibiotics till the patient has been afebrile for at least 24 hours. Following this, oral doxycycline with either metronidazole or clindamycin is given for 14 days. Ruptured abscess is treated surgically.</p>\n<p><strong>Stages of PID:</strong></p>\n<table>\n<tbody>\n<tr>\n<td>\n<p>Stage</p>\n</td>\n<td>\n<p>Condition</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage I </p>\n</td>\n<td>\n<p>Acute salpingitis without peritonitis—no adhesions</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage II </p>\n</td>\n<td>\n<p>Acute salpingitis with peritonitis—purulent discharge</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage III </p>\n</td>\n<td>\n<p>Acute salpingitis with superimposed tubal occlusion or tubo-ovarian complex </p>\n</td>\n</tr>\n<tr>\n<td>\n<p><strong>Stage IV</strong> </p>\n</td>\n<td>\n<p><strong>Ruptured tubo-ovarian abscess</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Stage V  </p>\n</td>\n<td>\n<p>Tubercular salpingitis</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p> </p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3422",
      "difficulty": "medium"
    }
  ]
}